[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,879,923,969,1057,1138,1205,1482,1556],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":776,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":786,"fullTextUrl":26,"authors":787,"publicationType":747,"publisherRelationship":863,"citationCount":26,"citationInfo":26,"publishDate":877,"publishYear":878,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"02a8e3ee-d8d6-41d8-86f5-5144853a9b0a","2024-01-11T06:50:21.574+00:00","2024-12-12T00:55:43.470+00:00",[],"Estrategia-de-diagn%C3%B3stico-prenatal-y-tratamiento-de-las-enfermedades-relacionadas-con-los-embarazos-m%C3%BAltiples",{"references":780,"title":782,"doi":784},{"VOID":781},"Evans, 2010, Screening and testing in multiples, Clin Lab Med, 30, 643, 10.1016\u002Fj.cll.2010.05.005\nVayssiere, 2010, Twin pregnancies: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF), Eur J Obstet Gynecol Reprod Biol, 156, 12, 10.1016\u002Fj.ejogrb.2010.12.045\nCuckle, 1998, Down's syndrome screening in twins, J Med Screen, 5, 3, 10.1136\u002Fjms.5.1.3\nSebire, 1997, The prevalence and consequences of missed abortion in twin pregnancies at 10 to 14 weeks of gestation, Br J Obstet Gynaecol, 104, 847, 10.1111\u002Fj.1471-0528.1997.tb12033.x\nSebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation, Br J Obstet Gynaecol, 103, 999, 10.1111\u002Fj.1471-0528.1996.tb09550.x\nOdibo, 2003, Screening for aneuploidy in twins and higher-order multiples: is first-trimester nuchal translucency the solution?, Obstet Gynecol Surv, 58, 609, 10.1097\u002F01.OGX.0000082369.30519.A8\nGlinianaia, 2008, Congenital anomalies in twins: a register-based study, Hum Reprod, 23, 1306, 10.1093\u002Fhumrep\u002Fden104\nBryan, 1987, Congenital anomalies in twins, Baillieres Clin Obstet Gynaecol, 1, 697, 10.1016\u002FS0950-3552(87)80012-3\nLewi, 2008, The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study, Am J Obstet Gynecol, 199, 514, 10.1016\u002Fj.ajog.2008.03.050\nSepulveda, 2005, Discordant lower urinary tract obstruction in early twin gestations: management and outcome, Obstet Gynecol, 106, 797, 10.1097\u002F01.AOG.0000175833.65983.ee\nWeber, 2010, Genetics and developmental pathology of twinning, Semin Fetal Neonatal Med, 15, 313, 10.1016\u002Fj.siny.2010.06.002\nWeisz, 2004, Tailored management of twin reversed arterial perfusion (trap) sequence, Ultrasound Obstet Gynecol, 23, 451, 10.1002\u002Fuog.1040\nNakata, 2008, Fetoscopic laser photocoagulation of placental communicating vessels for twin-reversed arterial perfusion sequence, J Obstet Gynaecol Res, 34, 649, 10.1111\u002Fj.1447-0756.2008.00901.x\nDiehl, 2007, Selective cord coagulation in acardiac twins, Semin Fetal Neonatal Med, 12, 458, 10.1016\u002Fj.siny.2007.06.008\nRossi, 2008, Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome: a meta-analysis and review of literature, Am J Obstet Gynecol, 198, 147, 10.1016\u002Fj.ajog.2007.09.043\nRoman, 2010, Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs. bipolar cord coagulation, Ultrasound Obstet Gynecol, 36, 37, 10.1002\u002Fuog.7567\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par foeticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007\nYamamoto, 2005, Incidence and impact of perioperative complications in 175 fetoscopy-guided laser coagulations of chorionic plate anastomoses in fetofetal transfusion syndrome before 26 weeks of gestation, Am J Obstet Gynecol, 193, 1110, 10.1016\u002Fj.ajog.2005.07.003\nQuintero, 1999, Staging of twin-twin transfusion syndrome, J Perinatol, 19, 550, 10.1038\u002Fsj.jp.7200292\nQuintero, 2003, Stage-based treatment of twin-twin transfusion syndrome, Am J Obstet Gynecol, 188, 1333, 10.1067\u002Fmob.2003.292\nHuber, 2006, Stage-related outcome in twin-twin transfusion syndrome treated by fetoscopic laser coagulation, Obstet Gynecol, 108, 333, 10.1097\u002F01.AOG.0000225945.17022.6b\nHarkness, 2005, Twin-twin transfusion syndrome: where do we go from here?, Semin Perinatol, 29, 296, 10.1053\u002Fj.semperi.2005.10.001\nRoberts, 2008, Interventions for twin-twin transfusion syndrome: a Cochrane review, Ultrasound Obstet Gynecol, 31, 701, 10.1002\u002Fuog.5328\nDelabaere, 2011, Résultats favorables d’une équipe émergente dans le traitement du syndrome transfuseur–transfusé par photocoagulation-laser, Gynecol Obstet Fertil, 39, 482, 10.1016\u002Fj.gyobfe.2011.02.016\nSlaghekke, 2010, Twin anemia-polycythemia sequence: diagnostic criteria, classification, perinatal management and outcome, Fetal Diagn Ther, 27, 181, 10.1159\u002F000304512\nLopriore, 2008, Fetal and neonatal haematological complications in monochorionic twins, Semin Fetal Neonatal Med, 13, 231, 10.1016\u002Fj.siny.2008.02.002\nLopriore, 2009, Residual anastomoses in twin-to-twin transfusion syndrome treated with selective fetoscopic laser surgery: localization, size, and consequences, Am J Obstet Gynecol, 201, 66, 10.1016\u002Fj.ajog.2009.01.010\nRobyr, 2006, Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome, Am J Obstet Gynecol, 194, 796, 10.1016\u002Fj.ajog.2005.08.069\nLewi, 2006, Pregnancy and infant outcome of 80 consecutive cord coagulations in complicated monochorionic multiple pregnancies, Am J Obstet Gynecol, 194, 782, 10.1016\u002Fj.ajog.2005.09.013\nHabli, 2009, Incidence of complications in twin-twin transfusion syndrome after selective fetoscopic laser photocoagulation: a single-center experience, Am J Obstet Gynecol, 201, 417, 10.1016\u002Fj.ajog.2009.07.046\nRussell, 2007, Intrauterine growth restriction in monochorionic twins, Semin Fetal Neonatal Med, 12, 439, 10.1016\u002Fj.siny.2007.06.004\nChang, 2009, Clinical outcome and placental territory ratio of monochorionic twin pregnancies and selective intrauterine growth restriction with different types of umbilical artery Doppler, Prenat Diagn, 29, 253, 10.1002\u002Fpd.2193\nDenbow, 2000, Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome, Am J Obstet Gynecol, 182, 417, 10.1016\u002FS0002-9378(00)70233-X\nLeduc, 2005, Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation, Am J Obstet Gynecol, 193, 1670, 10.1016\u002Fj.ajog.2005.04.007\nAcosta-Rojas, 2007, Twin chorionicity and the risk of adverse perinatal outcome, Int J Gynaecol Obstet, 96, 98, 10.1016\u002Fj.ijgo.2006.11.002\nGratacos, 2004, Prevalence of neurological damage in monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic umbilical artery flow, Ultrasound Obstet Gynecol, 24, 159, 10.1002\u002Fuog.1105\nIshii, 2009, Perinatal outcome of monochorionic twins with selective intrauterine growth restriction and different types of umbilical artery Doppler under expectant management, Fetal Diagn Ther, 26, 157, 10.1159\u002F000253880\nValsky, 2010, Selective intrauterine growth restriction in monochorionic twins: pathophysiology, diagnostic approach and management dilemmas, Semin Fetal Neonatal Med, 15, 342, 10.1016\u002Fj.siny.2010.07.002\nGratacos, 2007, A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin, Ultrasound Obstet Gynecol, 30, 28, 10.1002\u002Fuog.4046\nAxt, 1999, Maternal and neonatal outcome of twin pregnancies complicated by single fetal death, J Perinat Med, 27, 221, 10.1515\u002FJPM.1999.031\nLee, 2008, Twin chorionicity and the risk of stillbirth, Obstet Gynecol, 111, 301, 10.1097\u002FAOG.0b013e318160d65d\nOng, 2006, Prognosis for the co-twin following single-twin death: a systematic review, Bjog, 113, 992, 10.1111\u002Fj.1471-0528.2006.01027.x\nWoo, 2000, Single foetal death in twin pregnancies: review of the maternal and neonatal outcomes and management, Hong Kong Med J, 6, 293\nvan Heteren, 1998, Risk for surviving twin after fetal death of co-twin in twin-twin transfusion syndrome, Obstet Gynecol, 92, 215, 10.1016\u002FS0029-7844(98)00159-8\nBejar, 1990, Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations, Am J Obstet Gynecol, 162, 1230, 10.1016\u002F0002-9378(90)90024-2\nNicolini, 1999, Single intrauterine death in monochorionic twin pregnancies, Ultrasound Obstet Gynecol, 14, 297, 10.1046\u002Fj.1469-0705.1999.14050297.x\nSchinzel, 1979, Monozygotic twinning and structural defects, J Pediatr, 95, 921, 10.1016\u002FS0022-3476(79)80278-4\nMoore, 1969, Intrauterine disseminated intravascular coagulation: a syndrome of multiple pregnancy with a dead twin fetus, J Pediatr, 74, 523, 10.1016\u002FS0022-3476(69)80034-X\nWeisz, 2005, Invasive diagnostic procedures in twin pregnancies, Prenat Diagn, 25, 751, 10.1002\u002Fpd.1263\nNieuwint, 1999, “Identical” twins with discordant karyotypes, Prenat Diagn, 19, 72, 10.1002\u002F(SICI)1097-0223(199901)19:1\u003C72::AID-PD465>3.0.CO;2-V\nToth-Pal, 2004, Genetic amniocentesis in multiple pregnancy, Fetal Diagn Ther, 19, 138, 10.1159\u002F000075138\nMujezinovic, 2007, Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review, Obstet Gynecol, 110, 687, 10.1097\u002F01.AOG.0000278820.54029.e3\nDommergues, 1991, Embryo reduction in multifetal pregnancies after infertility therapy: obstetrical risks and perinatal benefits are related to operative strategy, Fertil Steril, 55, 805, 10.1016\u002FS0015-0282(16)54252-6\nEvans, 1994, Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases, Am J Obstet Gynecol, 170, 902, 10.1016\u002FS0002-9378(94)70306-X\nWapner, 1990, Selective reduction of multifetal pregnancies, Lancet, 335, 90, 10.1016\u002F0140-6736(90)90550-O\nSentilhes, 2008, Multifetal pregnancy reduction: indications, technical aspects and psychological impact, Presse Med, 37, 295, 10.1016\u002Fj.lpm.2007.05.016\nSenat, 2002, Funipuncture for fetocide in late termination of pregnancy, Prenat Diagn, 22, 354, 10.1002\u002Fpd.290\nBhide, 2002, Comparison of feticide carried out by cordocentesis versus cardiac puncture, Ultrasound Obstet Gynecol, 20, 230, 10.1046\u002Fj.1469-0705.2002.00797.x\nSenat, 2003, The use of lidocaine for fetocide in late termination of pregnancy, Bjog, 110, 296, 10.1046\u002Fj.1471-0528.2003.02217.x\nNielsen, 1991, Analgesic efficacy of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study, Reg Anesth, 16, 28\nRossi, 2009, Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature, Am J Obstet Gynecol, 200, 123, 10.1016\u002Fj.ajog.2008.08.039\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par fœticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007",{"ES":783},"Estrategia de diagnóstico prenatal y tratamiento de las enfermedades relacionadas con los embarazos múltiples",{"VOID":785},"10.1016\u002Fs1283-081x(13)65365-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X13653655",[788,803,815,827,839,851],{"id":789,"sortIndex":36,"researcher":26,"roles":790,"affiliations":791,"properties":800},"a6572e51-5aa5-4115-a749-b8be236a9f71",[696],[792],{"id":26,"sortIndex":36,"affiliation":793,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":796,"slug":26,"properties":797,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3677a859-5b95-42dd-85d4-27d0c50a01c8","2024-01-11T06:50:21.681+00:00",[],{"title":798},{"VI":799},"Pôle gynéco-obstétrique-reproduction humaine, Centre hospitalier universitaire de Clermont-Ferrand, Centre hospitalier universitaire Estaing, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France",{"title":801},{"VI":802},"A. Delabaere",{"id":804,"sortIndex":111,"researcher":26,"roles":805,"affiliations":806,"properties":812},"96b7792f-c31e-4cf1-a02e-3f39936930c8",[696],[807],{"id":26,"sortIndex":36,"affiliation":808,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":809,"slug":26,"properties":810,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":811},{"VI":799},{"title":813},{"VI":814},"D. Lémery",{"id":816,"sortIndex":114,"researcher":26,"roles":817,"affiliations":818,"properties":824},"caa7839d-08a4-44d3-8caf-161f5aa1e31b",[696],[819],{"id":26,"sortIndex":36,"affiliation":820,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":821,"slug":26,"properties":822,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":823},{"VI":799},{"title":825},{"VI":826},"F. Desvignes",{"id":828,"sortIndex":59,"researcher":26,"roles":829,"affiliations":830,"properties":836},"ded6f25d-5999-4755-a55e-a0f662dd5de9",[696],[831],{"id":26,"sortIndex":36,"affiliation":832,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":833,"slug":26,"properties":834,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":835},{"VI":799},{"title":837},{"VI":838},"H. Laurichesse-Delmas",{"id":840,"sortIndex":115,"researcher":26,"roles":841,"affiliations":842,"properties":848},"4755ec38-4344-4dc0-a5a3-5afcef6f72f5",[696],[843],{"id":26,"sortIndex":36,"affiliation":844,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":845,"slug":26,"properties":846,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":847},{"VI":799},{"title":849},{"VI":850},"S. Curinier",{"id":852,"sortIndex":162,"researcher":26,"roles":853,"affiliations":854,"properties":860},"444c2686-0290-4423-852c-e0810bccc815",[696],[855],{"id":26,"sortIndex":36,"affiliation":856,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":857,"slug":26,"properties":858,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":859},{"VI":799},{"title":861},{"VI":862},"D. Gallot",{"url":786,"publisher":864,"properties":872},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":865,"slug":662,"properties":866,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":869,"manageAffiliations":870,"indexDatabases":871,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":867,"title":868},{"VOID":665},{"EN":667},[],[],[],{"volume":873,"pages":875},{"VOID":874},"49",{"VOID":876},"1-11","2013-09-01",2013,{"id":880,"createTime":881,"updateTime":881,"relativeEntities":882,"slug":26,"properties":883,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":890,"fullTextUrl":26,"authors":891,"publicationType":747,"publisherRelationship":907,"citationCount":26,"citationInfo":26,"publishDate":921,"publishYear":922,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"1ad1c2b9-52c9-43b7-bb8c-582146d3f99d","2024-02-11T20:38:54.987+00:00",[],{"references":884,"title":886,"doi":888},{"VOID":885},"Tijo, 1956, The chromosome number of man, Hereditas, 42, 1, 10.1111\u002Fj.1601-5223.1956.tb03010.x\nLejeune, 1959, Étude des chromosomes somatiques de neuf enfants mongoliens, CR Acad Sci Paris, 248, 1721\nBoué, 1976, Diagnostic prénatal des anomalies chromosomiques, Arch Fr Pediatr, 33, 653\nBoué, 1979, Diagnostic prénatal : résultat de 1532 ponctions amniotiques et étude prospective de 1023 cas, Nouv Presse Med, 8, 2949\nBoué, 1984, A colla borative study of the segregation of inherited chromosome structural rearrangements in 1356 prenatal diagnoses, Prenat Diagn, 4, 45, 10.1002\u002Fpd.1970040705\nGoossens, 1981, Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic fluid cells. A preliminary study in the French West-Indies, Nouv Presse Med, 10, 387\nGoossens, 1983, Prenatal diagnosis of sickle-cell anemia in the first trimester of pregnancy, N Engl J Med, 309, 831, 10.1056\u002FNEJM198310063091405\nDaffos, 1983, Fetal blood sampling via the umbilical cord using a needle guided by ultrasound, Report of 66 cases. Prenat Diagn, 3, 271, 10.1002\u002Fpd.1970030402\nAgence de la biomédecine. Rapport médical et scientifique; 2020.\nNicolaides, 2004, Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities, Am J Obstet Gynecol, 191, 45, 10.1016\u002Fj.ajog.2004.03.090\nMuller, 2014, Dépistage de la trisomie 21 par les marqueurs sériques maternels : justification des commentaires appliqués par les biologistes, J Gynecol Obstet Biol Reprod, 43, 671, 10.1016\u002Fj.jgyn.2014.05.012\nHaute Autorité de santé. Recommandation : dépistage et diagnostic prénatals de la trisomie 21. Méthode de réalisation de l’outil d’information à destination des femmes enceintes ou des couples; 2018.\nHaute Autorité de santé. « Dépistage des trisomies »; 2019.\nLo, 2007, Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection, Nat Med, 13, 218, 10.1038\u002Fnm1530\nLo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet, 350, 485, 10.1016\u002FS0140-6736(97)02174-0\nHill, 2011, Non-invasive prenatal determination of fetal sex: translating research into clinical practice, Clin Genet, 80, 68, 10.1111\u002Fj.1399-0004.2010.01533.x\nLo, 1998, Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N Engl J Med, 339, 1734, 10.1056\u002FNEJM199812103392402\nTong, 2006, Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations, Clin Chem, 52, 2194, 10.1373\u002Fclinchem.2006.076851\nChiu, 2008, Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma, Proc Natl Acad Sci, 105, 20458, 10.1073\u002Fpnas.0810641105\nFan, 2008, Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood, Proc Natl Acad Sci, 105, 16266, 10.1073\u002Fpnas.0808319105\nPalomaki, 2011, DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study, Genet Med, 13, 913, 10.1097\u002FGIM.0b013e3182368a0e\nPalomaki, 2012, DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collab orative study, Genet Med, 14, 296, 10.1038\u002Fgim.2011.73\nChen, 2011, Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing, Plos One, 6\nLun, 2011, Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA, Clin Chem, 57, 917, 10.1373\u002Fclinchem.2011.161844\nCanick, 2012, DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations, Prenat Diagn, 32, 730, 10.1002\u002Fpd.3892\nHaute Autorité de santé. Recommandation : place des tests ADN libre circulant dans le sang maternel dans le dépistage de la trisomie 21 foetale; recommandation en santé publique; 2017.\nWang, 2015, Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases, Genet Med, 17, 234, 10.1038\u002Fgim.2014.92\nPoon, 2016, IONA test for first-trimester detection of trisomies 21, 18 and 13, Ultrasound Obstet Gynecol, 47, 184, 10.1002\u002Fuog.15749\nAssociation des cytogénéticiens de langue française. Recommandations sur la conduite à tenir devant l’identification d’anomalies chromosomiques foetales autres que les trisomies 13, 18 et 21 par l’étude de l’ADN libre circulant (ADNlc); 2020.\nLindquist, 2018, Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing, Ultrasound Obstet Gynecol, 51, 487, 10.1002\u002Fuog.18979\nFiorentino, 2017, The clinical utility of genome-wide non invasive prenatal screening, Prenat Diagn, 37, 593, 10.1002\u002Fpd.5053\nvan der Meij, 2019, TRIDENT-2: National implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands, Am J Hum Genet, 105, 1091, 10.1016\u002Fj.ajhg.2019.10.005\nEhrich, 2017, Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases, Genet Med, 19, 1332, 10.1038\u002Fgim.2017.56\nGross, 2016, Clinical experience with single-nucleotide polymorphism-based noninvasive prenatal screening for 22q11.2 deletion syndrome, Ultrasound Obstet Gynecol, 47, 177, 10.1002\u002Fuog.15754\nHelgeson, 2015, Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing, Prenat Diagn, 35, 999, 10.1002\u002Fpd.4640\nValderramos, 2016, screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results, Am J Obstet Gynecol, 215, 626, 10.1016\u002Fj.ajog.2016.06.039\nPei, 2020, Efficiency of noninvasive prenatal testing for the detection of fetal microdeletions and microduplications in autosomal chromosomes, Mol Genet Genomic Med, 8, 10.1002\u002Fmgg3.1339\nWu, 2020, Applying high-throughput sequencing to identify and evaluate foetal chromosomal deletion and duplication, J Cell Mol Med, 24, 9936, 10.1111\u002Fjcmm.15593\nRecommandations pour le dépistage des anomalies chromosomiques fœtales par l’étude de l’ADN libre circulant (ADNlc) ACLF V4. 2019.\nAssociation des cytogénéticiens de langue française. Arbre décisionnel : caryotype sur villosités choriales.\nCacheux, 1994, Evaluation of X, Y, 18, and 13\u002F21 alpha satellite DNA probes for interphase cytogenetic analysis of uncultured amniocytes by fluorescence in situ hybridization, Prenat Diagn, 14, 79, 10.1002\u002Fpd.1970140202\nMcGowan-Jordan J, Hastings Ros J., Moore S. In: ISCN: An international system for human cytogenetic nomenclature. Recommendations of the International Standing Committee on Human. Published in collaboration with Cytogenetic and Genome Research; 2020.\nShaffer, 2011, The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes, Prenat Diagn, 31, 778, 10.1002\u002Fpd.2766\nVialard, 2012, Prenatal BACs-on-Beads: the prospective experience of five prenatal diagnosis laboratories, Prenat Diagn, 32, 329, 10.1002\u002Fpd.2934\nDunbar, 2006, Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection, Clin Chim Acta, 363, 71, 10.1016\u002Fj.cccn.2005.06.023\nDe la Chapelle, 1981, A deletion in chromosome 22 can cause DiGeorge syndrome, Hum Genet, 57, 253, 10.1007\u002FBF00278938\nDupont, 2015, Prenatal diagnosis of 24 cases of microduplication 22q11.2: an investigation of phenotype-genotype correlations, Prenat Diagn, 35, 35, 10.1002\u002Fpd.4478\nGrati, 2013, Application of a new molecular technique for the genetic evaluation of products of conception, Prenat Diagn, 33, 32, 10.1002\u002Fpd.4004\nAchropuce. Guide de bonnes pratiques ACPA en diagnostic prénatal 2020 (v2.2).\nAssociation des cytogénéticiens de langue française. Guide de bonnes pratiques de cytogénétique (version 4); 2020.\nMcKinlay Gardner, 2018\nBoué, 1973, Outcome of pregnancies following a spontaneous abortion with chromosomal anomalies, Am J Obstet Gynecol, 161, 806, 10.1016\u002F0002-9378(73)91013-2\nPlachot, 1989, Chromosome analysis of spontaneous abortions after IVF. A European survey, Hum Reprod, 4, 425, 10.1093\u002Foxfordjournals.humrep.a136921\nTurleau, 2004, 71\nEdwards, 1960, A new trisomic syndrome, Lancet, 1, 787, 10.1016\u002FS0140-6736(60)90675-9\nPatau, 1960, Multiple congenital anomaly caused by an extra autosome, Lancet, 1, 790, 10.1016\u002FS0140-6736(60)90676-0\nPellestor, 1991, Frequency and distribution of aneuploidy in human female gametes, Hum Genet, 86, 283, 10.1007\u002FBF00202410\nHassold, 1993, Trisomy in human: incidence, origin and etiology, Curr Opin Genet Dev, 3, 398, 10.1016\u002F0959-437X(93)90111-2\nAngell, 1994, First meiotic division abnormalities in human aneuploidy in human ovocytes: mechanism of trisomy formation, Cytogenet Cell Genet, 65, 194, 10.1159\u002F000133631\nDe Grouchy, 1984\nSiffroi, 1997, Assisted reproductive technology and complex chromosomal rearrangements: the limits of ICSI, Mol Hum Reprod, 3, 847, 10.1093\u002Fmolehr\u002F3.10.847\nKeren, 2008, Nouveaux outils diagnostiques du retard mental, Mt Pediatr, 11, 230\nUnk, 2016, American College of Obstetricians and Gynecologists; Committee on Practice Bulletins–Obstetrics; Committee on Genetics; Society for Maternal–Fetal, Medicine, Practice Bulletin, No, 162, Obstet Gynecol, 127, e108\nAudibert, 2017, No. 348-Joint SOGC-CCMG Guideline: Update on prenatal screening for fetal aneuploidy, fetal anomalies, and adverse pregnancy outcomes, J Obstet Gynaecol Canada, 39, 805, 10.1016\u002Fj.jogc.2017.01.032\nDuncan, 2011, Use of array genomic hybridization technology in prenatal diagnosis in Canada, J Obstet Gynaecol Can, 33, 1256, 10.1016\u002FS1701-2163(16)35112-X\nArmour, 2018, Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada, J Med Genet, 55, 215, 10.1136\u002Fjmedgenet-2017-105013\nSteemers, 2006, Whole-genome genotyping with the single-base extension assay, Nat Methods, 3, 31, 10.1038\u002Fnmeth842\nMalan, 2012, Diagnosis of chromosomal abnormalities by array CGH in constitutional pathology: the end of the first-line karyotype. Diagnostic des anomalies chromosomiques par CGH array en pathologie constitutionnelle : la fin du caryotype en première intention, Arch Pediatr, 19, 437, 10.1016\u002Fj.arcped.2012.01.004\nCooper, 2011, A copy number variation morbidity map of developmental delay, Nat Genet, 43, 838, 10.1038\u002Fng.909\nConrad, 2010, Origins and functional impact of copy number variation in the human genome, Nature, 464, 704, 10.1038\u002Fnature08516\nLee, 2007, Copy number variations and clinical cytogenetic diagnosis of constitutional disorders, Nat Genet, 39, S48, 10.1038\u002Fng2092\nBreman, 2012, Prenatal chromosomal microarray analysis in a diagnostic laboratory: experience with >1000 cases and review of the literature, Prenat Diagn, 32, 351, 10.1002\u002Fpd.3861\nShaffer, 2012, Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies, Prenat Diagn, 32, 976, 10.1002\u002Fpd.3945\nHillman, 2013, Use of prenatal chromosomal microarray: Prospective cohort study and systematic review and meta-analysis, Ultrasound Obstet Gynecol, 41, 610, 10.1002\u002Fuog.12464\nDe Wit, 2014, Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: A systematic review of the literature, Ultrasound Obstet Gynecol, 43, 139, 10.1002\u002Fuog.12575\nMalan, 2016, A French approach to test fetuses with ultrasound abnormalities using a customized microarray as first-tier genetic test, Cytogenet Genome Res, 147, 103\nWapner, 2012, Chromosomal microarray versus karyotyping for prenatal diagnosis, N Engl J Med, 367, 2175, 10.1056\u002FNEJMoa1203382\nPapoulidis, 2015, Routine use of array comparative genomic hybridization (aCGH) as standard approach for prenatal diagnosis of chromosomal abnormalities. Clinical experience of 1763 prenatal cases, Prenat Diagn, 35, 1269, 10.1002\u002Fpd.4685\nSrebniak, 2016, array testing in 1000 fetuses with ultrasound anomalies: Causative, unexpected and susceptibility CNVs, Eur J Hum Genet, 24, 645, 10.1038\u002Fejhg.2015.193\nParchem, 2018, Utility of chromosomal microarray in anomalous fetuses, Prenat Diagn, 38, 140, 10.1002\u002Fpd.5202\nRachid, 2021, Six years of molecular cytogenetic in prenatal diagnosis: benefits, lessons and perspectives, Prenatal diagnosis\nPangalos, 2016, First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects, Peer J, 4, 10.7717\u002Fpeerj.1955\nNg, 2008, Genetic variation in an individual human exome, PLoS Genet, 4, 10.1371\u002Fjournal.pgen.1000160\nStenson, 2009, The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics, Hum Genomics, 4, 69, 10.1186\u002F1479-7364-4-2-69\nNg, 2009, Targeted capture and massively parallel sequencing of 12 human exomes, Nature, 461, 272, 10.1038\u002Fnature08250\nMcMullan DJ, Eberhardt R, Rinck G, et al. Exome sequencing of 406 parental\u002Ffetal trios with structural abnormalities revealed by ultrasound in the UK prenatal assessment of genomes and exomes (PAGE) Project. European Society of Human Genetics Copenhagen (Danemark); 2017.\nChandler, 2018, Rapid prenatal diagnosis using targeted exome sequencing: a cohort study to assess feasibility and potential impact on prenatal counseling and pregnancy management, Genet Med, 20, 1430, 10.1038\u002Fgim.2018.30\nAarabi, 2018, Importance of complete phenotyping in prenatal whole exome sequencing, Hum Genet, 137, 175, 10.1007\u002Fs00439-017-1860-1\nYadava, 2017, 125: Whole exome sequencing (WES) in prenatal diagnosis for carefully selected cases, Am J Obstet Gynecol, 216, S87, 10.1016\u002Fj.ajog.2016.11.029\nVora, 2017, Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges, Genet Med, 10.1038\u002Fgim.2017.33\nCarss, 2014, Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound, Hum Mol Genet, 23, 3269, 10.1093\u002Fhmg\u002Fddu038\nDaum, 2019, Collaborating authors. Fetal exome sequencing: yield and limitations in a single tertiary center, Ultrasound Obstet Gynecol, 53, 80, 10.1002\u002Fuog.19168\nYates, 2017, Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development, Genet Med, 19, 1171, 10.1038\u002Fgim.2017.31\nDrury, 2016, Prenatal diagnosis of sonographic abnormalities using rapid whole exome sequencing, Prenat Diagn, 36, 51\nLeung, 2018, Identifying the genetic causes for prenatally diagnosed structural congenital anomalies (SCAs) by whole-exome sequencing (WES), BMC Med Genomics, 11, 93, 10.1186\u002Fs12920-018-0409-z\nYang, 2014, Molecular findings among patients referred for clinical whole-exome sequencing, JAMA, 312, 1870, 10.1001\u002Fjama.2014.14601\nWalkiewicz M, Braxton A, Liu P, Xia PF, Bi W, Xiao R, et al. The utility of whole exome sequencing in prenatal diagnosis; Presented at the American Society of Human Genetics Annual Meeting: Vancouver; 2016.\nBarnett CP, Byrne A, Moore L, Khong Y, Manton N, Lipsett J, et al. The genomic autopsy: using whole exome and whole genome sequencing to solve complex fetal and neonatal presentations; Presented at the American Society of Human Genetics Annual Meeting: Vancouver; 2016.\nRyan E, Friedman B, Haskins A, Barbar R, Nelson Z, Al-Musafri F, et al. Whole exome sequencing in 129 fetuses with abnormal ultrasound findings; Presented at ACMG Annual Clinical Genetics Meeting; Phoenix, Arizona ; 2017.\nWapner, 2017, Whole exome sequencing in the evaluation of fetal structural anomalies: a prospective study of sequential patients, Am J Obstet Gynecol, 216, S5, 10.1016\u002Fj.ajog.2016.11.009\nLord, 2019, Prenatal Assessment of Genomes and Exomes Consortium. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study, Lancet, 393, 747, 10.1016\u002FS0140-6736(18)31940-8\nSá, 2018, Broad multi-gene panel or whole exome sequencing in malformed fetuses reveals eight definitive and one likely diagnoses in fifteen studied fetus, in prenatal setting, Eur J Hum Genet, 26, 129\nRichards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, 17, 405, 10.1038\u002Fgim.2015.30\nHarris, 2018, Ethical and counseling challenges in prenatal exome sequencing, Prenat Diagn, 38, 897, 10.1002\u002Fpd.5353\nHeide, 2020, Prenatal exome sequencing in 65 fetuses with abnormality of the corpus callosum: contribution to further diagnostic delineation, Genet Med, 22, 1887, 10.1038\u002Fs41436-020-0872-8\nConseil génétique. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-019-A-10].\nAlamillo, 2015, Exome sequencing positively identified relevant alterations in more than half of cases with an indication of prenatal ultrasound anomalies, Prenat Diagn, 35, 1073, 10.1002\u002Fpd.4648",{"ES":887},"Citogenética prenatal",{"VOID":889},"10.1016\u002Fs1283-081x(22)47073-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22470731",[892],{"id":893,"sortIndex":36,"researcher":26,"roles":894,"affiliations":895,"properties":904},"1ed569b5-be6c-4e55-89af-c49d6c802f3c",[696],[896],{"id":26,"sortIndex":36,"affiliation":897,"properties":26},{"id":898,"createTime":899,"updateTime":899,"relativeEntities":900,"slug":26,"properties":901,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4f06ffb7-7bf3-4e94-9265-6f6a982ecfa4","2024-02-11T20:38:55.006+00:00",[],{"title":902},{"VI":903},"Unité fonctionnelle de cytogénétique, Département de génétique, Hôpital Robert-Debré, AP–HP, 48, boulevard Serrurier, 75019 Paris, France",{"title":905},{"VI":906},"C. Dupont",{"url":890,"publisher":908,"properties":916},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":909,"slug":662,"properties":910,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":913,"manageAffiliations":914,"indexDatabases":915,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":911,"title":912},{"VOID":665},{"EN":667},[],[],[],{"volume":917,"pages":919},{"VOID":918},"58",{"VOID":920},"1-28","2022-12-01",2022,{"id":924,"createTime":925,"updateTime":926,"relativeEntities":927,"slug":928,"properties":929,"entityType":688,"verifyStatus":25,"verifyTime":926,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":936,"fullTextUrl":26,"authors":937,"publicationType":747,"publisherRelationship":953,"citationCount":26,"citationInfo":26,"publishDate":967,"publishYear":968,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e3b7365d-5885-47a7-aa82-8792121ec984","2024-01-27T19:53:28.745+00:00","2025-02-09T05:10:41.900+00:00",[],"Anestesia-y-analgesia-fetales",{"references":930,"title":932,"doi":934},{"VOID":931},"Deprest, 2008, Fetal surgery for anesthesiologists, Curr. Opin. Anaesthesiol., 21, 298, 10.1097\u002FACO.0b013e3282ff8607\nDe Buck, 2008, Anesthesia for fetal surgery, Curr. Opin. Anaesthesiol., 21, 293, 10.1097\u002FACO.0b013e3282fe6e70\nFarmer, 1998, Fetal surgery: a brief review, Pediatr. Radiol., 28, 409, 10.1007\u002Fs002470050372\nMagner, 2005\nBronstein, 1986, Visceral nociception in developing rats, Dev. Psychobiol., 19, 473, 10.1002\u002Fdev.420190508\nFitzgerald, 1985, The post-natal development of cutaneous afferent fibre input and receptive field organization in the rat dorsal horn, J. Physiol., 364, 1, 10.1113\u002Fjphysiol.1985.sp015725\nFitzgerald, 1988, The development of activity evoked by fine diameter cutaneous fibres in the spinal cord of the newborn rat, Neurosci. Lett., 86, 161, 10.1016\u002F0304-3940(88)90564-2\nFitzgerald, 1991, A physiological study of the prenatal development of cutaneous sensory inputs to dorsal horn cells in the rat, J. Physiol., 432, 473, 10.1113\u002Fjphysiol.1991.sp018395\nSmith, 2000, Pain and stress in the human fetus, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 161, 10.1016\u002FS0301-2115(00)00441-3\nSemba, 1982, Ontogeny of the peptidergic system in the rat spinal cord: immunohistochemical analysis, J. Comp. Neurol., 208, 54, 10.1002\u002Fcne.902080105\nLeong, 1984, Localizing spinal cord projecting neurons in neonatal and immature albino rats, J. Comp. Neurol., 228, 18, 10.1002\u002Fcne.902280104\nFitzgerald, 1987, The postnatal development of the ventral root reflex in the rat; a comparative in vivo and in vitro study, Neurosci. Lett., 78, 41, 10.1016\u002F0304-3940(87)90558-1\nPickel, 1982, Early prenatal development of substance P and enkephalin-containing neurons in the rat, J. Comp. Neurol., 210, 411, 10.1002\u002Fcne.902100407\nAnand, 1987, Pain and its effects in the human neonate and fetus, N. Engl. J. Med., 317, 1321, 10.1056\u002FNEJM198711193172105\nLecanuet, 1989, Sensorialité fœtale. Ontogenèse des systèmes sensoriels, conséquences de leur fonctionnement fœtal, 201\nLee, 2005, Fetal pain: a systematic multidisciplinary review of the evidence, JAMA, 294, 947, 10.1001\u002Fjama.294.8.947\nLowery, 2007, Neurodevelopmental changes of fetal pain, Semin. Perinatol., 31, 275, 10.1053\u002Fj.semperi.2007.07.004\nGiannakoulopoulos, 1994, Fetal plasma cortisol and β-endorphin response to intrauterine needling, Lancet, 344, 77, 10.1016\u002FS0140-6736(94)91279-3\nSulmasy, 1999, The rule of double effect: clearing up the double talk, Arch. Intern. Med., 159, 545, 10.1001\u002Farchinte.159.6.545\nGerdin, 1990, Transplacental transfer of morphine in man, J. Perinat. Med., 18, 305, 10.1515\u002Fjpme.1990.18.4.305\nSpielman, 1984, Anesthesia for fetal surgery, Anesthesia, 39, 756, 10.1111\u002Fj.1365-2044.1984.tb06517.x\nSpencer, 1994, The effect of neuromuscular blockade on human fetal heart rate and its variation, Br. J. Obstet. Gynaecol., 101, 121, 10.1111\u002Fj.1471-0528.1994.tb13076.x\nDaffos, 1988, Fetal curarization for prenatal magnetic resonance imaging, Prenat. Diagn., 8, 312, 10.1002\u002Fpd.1970080412\nWilliamson, 1989, Magnetic resonance imaging of anomalous fetuses, Obstet. Gynecol., 73, 952\nRevel, 1993, Magnetic resonance imaging of the fetus: a study of 20 cases performed without curarization, Prenat. Diagn., 13, 775, 10.1002\u002Fpd.1970130902\nMyers, 2004, Fetal endoscopic surgery: indications and anaesthetic management, Best Pract. Res. Clin. Anaesthesiol., 18, 231, 10.1016\u002Fj.bpa.2004.01.001\nMyers, 2004, Epidural versus general anesthesia for twin-twin transfusion syndrome requiring fetal surgery, Fetal Diagn. Ther., 19, 286, 10.1159\u002F000076713\nFisk, 2001, Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling, Anesthesiology, 95, 828, 10.1097\u002F00000542-200110000-00008\nHaram, 1980, Diazepam as an induction agent for caesarean section: a clinical and pharmacological study of fetal exposure, Br. J. Obstet. Gynaecol., 87, 506, 10.1111\u002Fj.1471-0528.1980.tb04587.x\nJauniaux, 1996, In-vivo study of diazepam transfer across the first trimester human placenta, Hum. Reprod., 11, 889, 10.1093\u002Foxfordjournals.humrep.a019272\nMissant, 2004, Remifentanil for foetal immobilisation and maternal sedation during endoscopic treatment of twin-to-twin transfusion syndrome: a preliminary dose-finding study, Acta Anaesthesiol. Belg., 55, 239\nMoise, 1989, Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization, Obstet. Gynecol., 74, 905\nNatori M, Ishimoto H, Myazaki T. Intervention in the fetuses with pleural effusion. [Abstract]. 2nd World congress of Perinatal Medicine, Rome, 1993.\nNakano, 1991, Anesthesia for cesarean section in patients with fetal anomaly, Masui, 40, 738\nHanley, 1994, Fetal cardiac surgery, Adv. Card. Surg., 5, 47\nHarrison, 1990, Antenatal intervention for congenital cystic adenomatoid malformation, Lancet, 336, 965, 10.1016\u002F0140-6736(90)92420-M\nEsteve, 1992, Bilan de cinq années de chirurgie expérimentale in utero pour la réparation des hernies diaphragmatiques, Ann. Fr. Anesth. Reanim., 11, 193, 10.1016\u002FS0750-7658(05)80012-7\nRychik, 2004, Acute cardiovascular effects of fetal surgery in the human, Circulation, 110, 1549, 10.1161\u002F01.CIR.0000142294.95388.C4\nGoodman, 1997, Changing tactics in the abortion argument: does a fetus feel pain?, Br. J. Hosp. Med., 58, 550\nMcMahan, 2006, Paradoxes of abortion and prenatal injury, Ethics, 116, 625, 10.1086\u002F504621\nWenger, 2006, Fetal pain legislation. Subordinating sound medical findings to moral and political agendas, J. Leg. Med., 27, 459, 10.1080\u002F01947640601021089\n2005, Respecting women's rights and fetal value: reflections on the question of fetal anesthesia, Conscience, 26, 39\nPreston, 2004, NY US Court in New York rejects partial-birth abortion ban, Times, A12\nGupta, 2007, On the nature, assessment, and treatment of fetal pain: neurobiological bases, pragmatic issues, and ethical concerns, Pain Phys, 10, 525\nSenat, 2002, Funipuncture for fetocide in late termination of pregnancy, Prenat. Diagn., 22, 354, 10.1002\u002Fpd.290\nNielsen, 1991, Analgesic efficacy of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study, Reg. Anesth., 16, 28\nSenat, 2003, The use of lidocaine for fetocide in late termination of pregnancy, BJOG, 110, 296, 10.1046\u002Fj.1471-0528.2003.02217.x",{"ES":933},"Anestesia y analgesia fetales",{"VOID":935},"10.1016\u002Fs1283-081x(09)70784-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707842",[938],{"id":939,"sortIndex":36,"researcher":26,"roles":940,"affiliations":941,"properties":950},"11214995-34e8-4643-9bd6-5f5854c6190d",[696],[942],{"id":26,"sortIndex":36,"affiliation":943,"properties":26},{"id":944,"createTime":945,"updateTime":945,"relativeEntities":946,"slug":26,"properties":947,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"14238574-459e-4dc0-8c5c-1e270f52bbe8","2024-01-27T19:53:28.757+00:00",[],{"title":948},{"VI":949},"Service de réanimation et médecine néonatale, Centre hospitalier de Poissy-Saint-Germain-en-Laye, 10, rue du Champ-Gaillard, 78303 Poissy, France",{"title":951},{"VI":952},"R. Lenclen",{"url":936,"publisher":954,"properties":962},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":955,"slug":662,"properties":956,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":959,"manageAffiliations":960,"indexDatabases":961,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":957,"title":958},{"VOID":665},{"EN":667},[],[],[],{"volume":963,"pages":965},{"VOID":964},"45",{"VOID":966},"1-6","2009-01-01",2009,{"id":970,"createTime":971,"updateTime":972,"relativeEntities":973,"slug":974,"properties":975,"entityType":688,"verifyStatus":25,"verifyTime":972,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":982,"fullTextUrl":26,"authors":983,"publicationType":747,"publisherRelationship":1043,"citationCount":26,"citationInfo":26,"publishDate":1056,"publishYear":922,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e33e2165-7691-4ef0-87ff-7b731705e761","2024-01-17T20:17:37.133+00:00","2024-12-13T12:49:32.410+00:00",[],"Tratamiento-quir%C3%BArgico-de-las-lesiones-de-la-gl%C3%A1ndula-de-Bartholin-y-las-lesiones-benignas-de-la-vagina",{"references":976,"title":978,"doi":980},{"VOID":977},"Paniel BJ, Truc JB, Robichez B, Malouf A, Poitout P. Chirurgie des lésions bénignes de la vulve. EMC (Elsevier Masson SAS, Paris). Techniques chirurgicales - Urologie-Gynécologie, 41-885, 1985.\nGabriel R, Quereux C, Wahl P. Tumeurs bénignes de la vulve. EMC (Elsevier Masson SAS, Paris). Gynecologie, 510-A-10, 1995.\nKamina, 1984\nOmole, 2003, Management of Bartholin's duct cyst and gland abscess, Am Fam Physician, 68, 135\nPundir, 2008, A review of the management of diseases of the Bartholin's gland, J Obstet Gynaecol, 28, 161, 10.1080\u002F01443610801912865\nMarzano, 2004, The bartholin gland cyst: past, present, and future, J Low Genit Tract Dis, 8, 195, 10.1097\u002F00128360-200407000-00006\nAydogan Mathyk, 2018, Sexual function after Bartholin gland abscess treatment: a randomized trial of the marsupialization and excision methods, Eur J Obstet Gynecol Reprod Biol, 230, 188, 10.1016\u002Fj.ejogrb.2018.10.015\nEglin G. Marsupialisation ou ablation de la glande de Bartholin : techniques chirurgicales et indications. Extrait des mises à jour en gynécologie et obstétrique. CNGOF Tome XXXIII publié le 9.12.2009.\nCardaillac, 2019, Surgical management of Bartholin cysts and abscesses in French university hospitals, J Gynecol Obstet Hum Reprod, 48, 631, 10.1016\u002Fj.jogoh.2019.03.022\nDescamps P, Racine-Thibaud AC, Eglin G, Catala L, Lefèbvre-Lacœuille C, Sentilhes L, et al. Conduite à tenir devant une bartholinite. Extrait des mises à jour en gynécologie médicale. CNGOF Volume 2007 publié le 12.12.2007.\nCho, 1990, Window operation: an alternative treatment method for Bartholin gland cysts and abscesses, Obstet Gynecol, 76, 886, 10.1097\u002F00006250-199011000-00034\nKroese, 2017, Word catheter and marsupialisation in women with a cyst or abscess of the Bartholin gland (WoMan-trial): a randomised clinical trial, BJOG, 124, 243, 10.1111\u002F1471-0528.14281\nEglin, 2007, Comment je fais une bartholinectomie ?, Gynecol Obstet Fertil, 35, 1268, 10.1016\u002Fj.gyobfe.2007.07.038\nRock, 1997, 644\nMarkusen, 2003, Benign disorders of the vulva and vagina, 651\nCornman-Homonoff, 2018, Transarterial embolization of a Bartholin cyst before resection, J Minim Invasive Gynecol, 25, 938, 10.1016\u002Fj.jmig.2017.11.016\nHaider, 2007, The simple outpatient management of Bartholin's abscess using the Word catheter: a preliminary study, Aust N Z J Obstet Gynaecol, 47, 137, 10.1111\u002Fj.1479-828X.2007.00700.x\nWord, 1964, New instrument for office treatment of cyst and abscess of Bartholin's gland, JAMA, 190, 777, 10.1001\u002Fjama.1964.03070210083024\nGoldberg, 1970, Simplified tratment for disease of Bartholin's gland, Obstet Gynecol, 35, 109\nScott, 2003, Draining a cyst or abscess in a Bartholin's gland with a Word catheter, JAAPA, 16, 51\nOwen, 2005, Placement of a Word catheter: a resident training model, Am J Obstet Gynecol, 192, 1385, 10.1016\u002Fj.ajog.2005.02.078\nReif, 2015, Management of Bartholin's cyst and abscess using the Word catheter: implementation, recurrence rates and costs, Eur J Obstet Gynecol Reprod Biol, 190, 81, 10.1016\u002Fj.ejogrb.2015.04.008\nCobellis, 2006, Alcohol sclerotherapy: a new method for Bartholin gland cyst treatment, Minerva Ginecol, 58, 245\nKafali, 2004, Aspiration and alcohol sclerotherapy: a novel method for management of Bartholin's cyst or abscess, Eur J Obstet Gynecol Reprod Biol, 112, 98, 10.1016\u002FS0301-2115(03)00241-0\nFambrini, 2008, Carbon-dioxide laser vaporization of the Bartholin gland cyst: a retrospective analysis on 200 cases, J Minim Invasive Gynecol, 15, 327, 10.1016\u002Fj.jmig.2008.02.005\nDavis, 1985, Management of Bartholin duct cysts with the carbon dioxide laser, Obstet Gynecol, 65, 279\nBenedetti Panici, 2007, CO2 laser therapy of the Bartholin's gland cyst: surgical data and functional short- and long-term results, J Minim Invasive Gynecol, 14, 348, 10.1016\u002Fj.jmig.2006.10.015\nLashgari, 1986, Excision of Bartholin duct cysts using the CO2 laser, Obstet Gynecol, 67, 735, 10.1097\u002F00006250-198605000-00024\nMungan, 1995, Treatment of Bartholin's cyst and abscess: excision versus silver nitrate insertion, Eur J Obstet Gynecol Reprod Biol, 63, 61, 10.1016\u002F0301-2115(95)02229-Z\nErgeneli, 1999, Silver nitrate for Bartholin gland cysts, Eur J Obstet Gynecol Reprod Biol, 82, 231, 10.1016\u002FS0301-2115(98)00229-2\nYüce, 1994, Outpatient management of Bartholin gland abscesses and cysts with silver nitrate, Aust N Z J Obstet Gynaecol, 34, 93, 10.1111\u002Fj.1479-828X.1994.tb01048.x\nTuran, 1995, The treatment of Bartholin's cyst and abscess with silver nitrate, Int J Gynaecol Obstet, 48, 31, 10.1016\u002F0020-7292(94)02299-E\nOzdegirmenci, 2009, Prospective randomised study of marsupialisation versus silver nitrate application in the management of bartholin gland cysts and abscesses, J Minim Invasive Gynecol, 16, 149, 10.1016\u002Fj.jmig.2008.10.006\nWechter, 2009, Management of Bartholin duct cysts and abscesses: a systematic review, Obstet Gynecol Surv, 64, 395, 10.1097\u002FOGX.0b013e31819f9c76\nEilber, 2003, Benign cystic lesions of the vagina: a literature review, J Urol, 170, 717, 10.1097\u002F01.ju.0000062543.99821.a2\nHart, 1970, Paramesonephric mucinous cysts of the vulva, Am J Obstet Gynecol, 107, 1079, 10.1016\u002F0002-9378(70)90632-0\nKaufman, 1994\nWilkinson, 1987\nRouzier, 2005, Unusual presentation of Bartholin's gland duct cysts: anterior expansions, BJOG, 112, 1150, 10.1111\u002Fj.1471-0528.2005.00622.x\nYoussef, 1984\nCurrarino, 1982, Single vaginal ectopic ureter and Gartner's duct cyst with ipsilateral renal hypoplasia and dysplasia (or agenesis), J Urol, 128, 988, 10.1016\u002FS0022-5347(17)53311-X\nSheih, 1994, Renal hypoplasia, Gartner's duct and imperforated hemivagina: report of a case, J Formos Med Assoc, 93, 531\nDwyer, 2006, Congenital urogenital anomalies that are associated with the persistence of Gartner's duct: a review, Am J Obstet Gynecol, 195, 354, 10.1016\u002Fj.ajog.2005.10.815\nHagspiel, 1995, Giant Gartner duct cyst: magnetic resonance imaging findings, Abdom Imaging, 20, 566, 10.1007\u002FBF01256713\nFletcher, 2008, Benign masses of the female periurethral tissues and anterior vaginal wall, Curr Urol Rep, 9, 389, 10.1007\u002Fs11934-008-0067-3\nZaino RJ, Robboy SJ, Kurman RJ. Diseases of the vagina. In: Kurman R.J. Blaunstein's pathology of the female genital tract 2002; New York: Springer; 151.\nRosai, 2004, Female reproductive system: vagina\nRomanzi, 2000, Urethral diverticulum in women: diverse presentations resulting in diagnostic delay and mismanagement, J Urol, 164, 428, 10.1016\u002FS0022-5347(05)67377-6\nGanabathi, 1995, Diverticulum of the female urethra, Prog Urol, 5, 335\nHosseinzadeh, 2008, Pre- and postoperative evaluation of urethral diverticulum, AJR Am J Roentgenol, 190, 165, 10.2214\u002FAJR.07.2094",{"ES":979},"Tratamiento quirúrgico de las lesiones de la glándula de Bartholin y las lesiones benignas de la vagina",{"VOID":981},"10.1016\u002Fs1283-081x(22)46467-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22464678",[984,999,1016,1028],{"id":985,"sortIndex":59,"researcher":26,"roles":986,"affiliations":987,"properties":996},"5c2e52d0-b2a5-42d9-8519-6f4d4ba5e407",[696],[988],{"id":26,"sortIndex":36,"affiliation":989,"properties":26},{"id":990,"createTime":991,"updateTime":991,"relativeEntities":992,"slug":26,"properties":993,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1c8896d6-12bd-4872-b593-b504b2e8c36d","2024-02-12T03:26:57.966+00:00",[],{"title":994},{"VI":995},"Service de gynécologie obstétrique, Hôpital La-Conception, 147, boulevard Baille, 13005 Marseille, France",{"title":997},{"VI":998},"A. Agostini",{"id":1000,"sortIndex":36,"researcher":26,"roles":1001,"affiliations":1002,"properties":1013},"3a1277ab-adf2-4f94-86d5-9be6ddb00918",[696],[1003],{"id":26,"sortIndex":36,"affiliation":1004,"properties":26},{"id":1005,"createTime":1006,"updateTime":1007,"relativeEntities":1008,"slug":1009,"properties":1010,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"00288498-e422-4b6b-85dc-887ce2f6da9c","2023-12-12T05:27:05.124+00:00","2025-06-11T13:40:00.350+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-H%C3%B4pital-La-Conception-147-boulevard-Baille-13005-Marseille-France",{"title":1011},{"VI":1012},"Service de gynécologie-obstétrique, Hôpital La Conception, 147, boulevard Baille, 13005 Marseille, France",{"title":1014},{"VI":1015},"C. Tourette",{"id":1017,"sortIndex":115,"researcher":26,"roles":1018,"affiliations":1019,"properties":1025},"6292c3af-06ba-4f5d-bbd8-3f2b3dc49648",[696],[1020],{"id":26,"sortIndex":36,"affiliation":1021,"properties":26},{"id":1005,"createTime":1006,"updateTime":1007,"relativeEntities":1022,"slug":1009,"properties":1023,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1024},{"VI":1012},{"title":1026},{"VI":1027},"A. Bedel",{"id":1029,"sortIndex":114,"researcher":26,"roles":1030,"affiliations":1031,"properties":1040},"5fe6ff22-97e8-4c9a-b3bd-209a78e09edd",[696],[1032],{"id":26,"sortIndex":36,"affiliation":1033,"properties":26},{"id":1034,"createTime":1035,"updateTime":1035,"relativeEntities":1036,"slug":26,"properties":1037,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"cc568792-e93f-480e-a13c-2342d2989693","2024-01-17T20:17:37.176+00:00",[],{"title":1038},{"VI":1039},"Institut Paoli-Calmette, 232, boulevard Sainte-Marguerite, 13009 Marseille, France",{"title":1041},{"VI":1042},"M. Provansal",{"url":982,"publisher":1044,"properties":1052},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1045,"slug":662,"properties":1046,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1049,"manageAffiliations":1050,"indexDatabases":1051,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1047,"title":1048},{"VOID":665},{"EN":667},[],[],[],{"volume":1053,"pages":1054},{"VOID":918},{"VOID":1055},"1-8","2022-05-01",{"id":1058,"createTime":1059,"updateTime":1060,"relativeEntities":1061,"slug":1062,"properties":1063,"entityType":688,"verifyStatus":25,"verifyTime":1060,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1069,"fullTextUrl":26,"authors":1070,"publicationType":747,"publisherRelationship":1122,"citationCount":26,"citationInfo":26,"publishDate":1136,"publishYear":1137,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a87a1a9c-6865-41b6-87ff-810a872d758e","2024-02-13T05:30:52.866+00:00","2024-12-13T12:49:32.514+00:00",[],"Salpingoscopia",{"references":1064,"title":1066,"doi":1067},{"VOID":1065},"Smith, 1849, New method of treating sterility by removal obstructions of the fallopian tubes, Lancet, 1, 529, 10.1016\u002FS0140-6736(02)65312-7\nMori, 1970, Tubaloscope: flexible glass fiber endoscope for intratubal observations, Endoscopy, 2, 226, 10.1055\u002Fs-0028-1098472\nCornier, 1985, Per-celioscopic ampullosalpingoscopy, J Gynecol Obstet Biol Reprod (Paris), 14, 459\nSurrey, 1999, Microendoscopy of the human fallopian tube, JAm Assoc Gynecol Laparosc, 6, 383, 10.1016\u002FS1074-3804(99)80003-6\nKerin, 1996, antegrade imaging in the management of oviductal disease, J Am Assoc Gynecol Laparosc, 3, S21, 10.1016\u002FS1074-3804(96)80203-9\nDechaud, 1998, Prospective evaluation of falloposcopy, Hum Reprod, 13, 1815, 10.1093\u002Fhumrep\u002F13.7.1815\nGordts, 2005, Transvaginal laparoscopy, Best Pract Res Clin Obstet Gynaecol, 19, 757, 10.1016\u002Fj.bpobgyn.2005.06.005\nWatrelot, 1999, Evaluation of the performance of fertiloscopy in 160 consecutive infertile patients with no obvious pathology, Hum Reprod, 14, 707, 10.1093\u002Fhumrep\u002F14.3.707\nHerrlinger, 1964, Why did vesalius not discover the fallopian tubes?, Med Hist, 8, 335, 10.1017\u002FS002572730002980X\nCorfman, 1966, An instrument for transcervical treatment of the oviducts and uterine cornua, Obstet Gynecol, 27, 880\nRouanet, 1977, An application of selective catheterization: salpingography, Preliminary note. Nouv Presse Med, 6, 2785\nCornier, 1982, Fibroscopy in gynecology: fibrohysteroscopy and fibrotuboscopy, Nouv Presse Med, 11, 2841\nPlatia, 1985, Transvaginal fluoroscopic recanalization of a proximally occluded oviduct, Fertil Steril, 44, 704, 10.1016\u002FS0015-0282(16)48992-2\nHenry-Suchet, 1985, Endoscopy of the tube (= tuboscopy): its prognostic value for tuboplasties, Acta Eur Fertil, 16, 139\nConfino, 1986, Transcervical balloon tuboplasty, Fertil Steril, 46, 963, 10.1016\u002FS0015-0282(16)49844-4\nBrosens, 1987, Salpingoscopy: a new pre-operative diagnostic tool in tubal infertility, Br J Obstet Gynaecol, 94, 768, 10.1111\u002Fj.1471-0528.1987.tb03724.x\nKerin, 1990, Falloposcopy: a microendoscopic technique for visual exploration of the human fallopian tube from the uterotubal ostium to the fimbria using a transvaginal approach, Fertil Steril, 54, 390, 10.1016\u002FS0015-0282(16)53750-9\nGordts, 1998, Transvaginal hydrolaparoscopy as an outpatient procedure for infertility investigation, Hum Reprod, 13, 99, 10.1093\u002Fhumrep\u002F13.1.99\nPuttemans, 1998, A decade of salpingoscopy, Eur J Obstet Gynecol Reprod Biol, 81, 197, 10.1016\u002FS0301-2115(98)00191-2\nMarana, 1995, Correlation between the American Fertility Society classifications of adnexal adhesions and distal tubal occlusion, salpingoscopy, and reproductive outcome in tubal surgery, Fertil Steril, 64, 924, 10.1016\u002FS0015-0282(16)57903-5\nSuzuki, 2005, Feasibility and clinical significance of endoluminal assessment by transvaginal salpingoscopy during transvaginal hydrolaparoscopy in infertile women, J Minim Invasive Gynecol, 12, 420, 10.1016\u002Fj.jmig.2005.06.014\nWatrelot, 2003, Is laparoscopy still the gold standard in infertility assessment? Acomparison of fertiloscopy versus laparoscopy in infertility. Results of an international multicentre prospective trial: the ‘FLY’ (Fertiloscopy-LaparoscopY) study, Hum Reprod, 18, 834, 10.1093\u002Fhumrep\u002Fdeg180\nDechaud, 2001, Does transvaginal hydrolaparoscopy render standard diagnostic laparoscopy obsolete for unexplained infertility investigation?, Eur J Obstet Gynecol Reprod Biol, 94, 97, 10.1016\u002FS0301-2115(00)00305-5\nWatrelot, 2002, Systematic salpingoscopy and microsalpingoscopy during fertiloscopy, J Am Assoc Gynecol Laparosc, 9, 453, 10.1016\u002FS1074-3804(05)60518-X\nWatrelot, 2003, Advances in the assessment of the uterus and fallopian tube function, Best Pract Res Clin Obstet Gynaecol, 17, 187, 10.1016\u002FS1521-6934(02)00131-1\nMarconi, 1998, Methylene blue dyeing of cellular nuclei during salpingoscopy, a new in-vivo method to evaluate vitality of tubal epithelium, Hum Reprod, 13, 3414, 10.1093\u002Fhumrep\u002F13.12.3414\nDe Bruyne, 1989, The clinical value of salpingoscopy in tubal infertility, Fertil Steril, 51, 339, 10.1016\u002FS0015-0282(16)60501-0\nMarana, 2003, Salpingoscopy, Curr Opin Obstet Gynecol, 15, 333, 10.1097\u002F01.gco.0000084245.09900.dd\nMarchino, 2001, Salpingoscopic and laparoscopic investigations in relation to fertility outcome, J AmAssoc Gynecol Laparosc, 8, 218, 10.1016\u002FS1074-3804(05)60581-6\nMarana, 1999, The prognostic role of salpingoscopy in laparoscopic tubal surgery, Hum Reprod, 14, 2991, 10.1093\u002Fhumrep\u002F14.12.2991\nDe Bruyne, 1997, The prognostic value of salpingoscopy, Hum Reprod, 12, 266, 10.1093\u002Fhumrep\u002F12.2.266\nVasquez, 1995, Prospective study of tubal mucosal lesions and fertility in hydrosalpinges, Hum Reprod, 10, 1075, 10.1093\u002Foxfordjournals.humrep.a136097\nVerhoeven, 2005, Transvaginal hydrolaparoscopy, its history and present indication, Minim Invasive Ther Allied Technol, 14, 175, 10.1080\u002F13645700510033949\nVan Tetering, 2007, Prognostic capacity of transvaginal hydrolaparoscopy to predict spontaneous pregnancy, Hum Reprod, 22, 1091, 10.1093\u002Fhumrep\u002Fdel501",{"ES":1062},{"VOID":1068},"10.1016\u002Fs1283-081x(08)70813-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708130",[1071,1086,1098,1110],{"id":1072,"sortIndex":115,"researcher":26,"roles":1073,"affiliations":1074,"properties":1083},"9eef688c-9e4f-478e-b81a-2a9c607ba457",[696],[1075],{"id":26,"sortIndex":36,"affiliation":1076,"properties":26},{"id":1077,"createTime":1078,"updateTime":1078,"relativeEntities":1079,"slug":26,"properties":1080,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8918999a-8fdf-4b2d-8da1-ddf9eff2215d","2024-02-13T05:30:52.906+00:00",[],{"title":1081},{"VI":1082},"Département de médecine et biologie de la reproduction, CHU Arnaud-de-Villeneuve, Université Montpellier I, Faculté de Médecine de Montpellier, 371, avenue du doyen G.-Giraud, 34295 Montpellier cedex 5, France",{"title":1084},{"VI":1085},"C. Dechanet",{"id":1087,"sortIndex":114,"researcher":26,"roles":1088,"affiliations":1089,"properties":1095},"299bdb00-0cfd-415c-8afd-a381d8296d09",[696],[1090],{"id":26,"sortIndex":36,"affiliation":1091,"properties":26},{"id":1077,"createTime":1078,"updateTime":1078,"relativeEntities":1092,"slug":26,"properties":1093,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1094},{"VI":1082},{"title":1096},{"VI":1097},"J. Faidherbe",{"id":1099,"sortIndex":36,"researcher":26,"roles":1100,"affiliations":1101,"properties":1107},"e3dc085d-46ed-4a14-bb72-b65d1312fc39",[696],[1102],{"id":26,"sortIndex":36,"affiliation":1103,"properties":26},{"id":1077,"createTime":1078,"updateTime":1078,"relativeEntities":1104,"slug":26,"properties":1105,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1106},{"VI":1082},{"title":1108},{"VI":1109},"H. Dechaud",{"id":1111,"sortIndex":59,"researcher":26,"roles":1112,"affiliations":1113,"properties":1119},"4c9e432c-6e4f-499b-a581-2b232ef601db",[696],[1114],{"id":26,"sortIndex":36,"affiliation":1115,"properties":26},{"id":1077,"createTime":1078,"updateTime":1078,"relativeEntities":1116,"slug":26,"properties":1117,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1118},{"VI":1082},{"title":1120},{"VI":1121},"B. Hedon",{"url":1069,"publisher":1123,"properties":1131},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1124,"slug":662,"properties":1125,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1128,"manageAffiliations":1129,"indexDatabases":1130,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1126,"title":1127},{"VOID":665},{"EN":667},[],[],[],{"volume":1132,"pages":1134},{"VOID":1133},"44",{"VOID":1135},"1-5","2008-01-01",2008,{"id":1139,"createTime":1140,"updateTime":1140,"relativeEntities":1141,"slug":26,"properties":1142,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1149,"fullTextUrl":26,"authors":1150,"publicationType":747,"publisherRelationship":1190,"citationCount":26,"citationInfo":26,"publishDate":1203,"publishYear":1204,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e4ac5b66-eae3-4d43-bc88-c34a1ef5d73a","2023-12-12T03:53:07.952+00:00",[],{"references":1143,"title":1145,"doi":1147},{"VOID":1144},"Ibanez, 2000, Premature adrenarche: normal variant or forerunner of adult disease?, Endocr. Rev., 21, 671, 10.1210\u002Fer.21.6.671\nApter, 1993, Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins, J. Clin. Endocrinol. Metab., 76, 940, 10.1210\u002Fjc.76.4.940\nIbanez, 1998, Possible genesis of polycystic ovary syndrom in the periadolescent girl, Curr. Opin. Endocrinol Diab, 5, 19, 10.1097\u002F00060793-199802000-00004\nvan Hooff, 2004, Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years, Hum. Reprod., 19, 383, 10.1093\u002Fhumrep\u002Fdeh079\nLobo, 1991, Ovarian hyperandrogenism and androgen producing tumors, Endocrinol. Metab. Clin. North Am., 20, 773, 10.1016\u002FS0889-8529(18)30244-5\nYoung, 1985, Ovarian Sertoli-Leydig cell tumors: a clinicopathological analysis of 207 cases, Am. J. Surg. Pathol., 9, 543, 10.1097\u002F00000478-198508000-00001\nCaron, 1993, Androgenic granulosa cell tumor of the ovary: in vivo hormonal studies, J. Endocrinol. Invest., 16, 545, 10.1007\u002FBF03348903\nAbbott, 2002, Developmental origin of polycystic ovary syndrome-a hypothesis, J. Endocrinol., 174, 1, 10.1677\u002Fjoe.0.1740001\nStrauss, 1999, Molecular mysteries of polycystic ovary syndrome, Mol. Endocrinol., 13, 800, 10.1210\u002Fme.13.6.800\nDunaif, 1997, Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis, Endocr. Rev., 18, 774, 10.1210\u002Fer.18.6.774\nWebber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016\u002FS0140-6736(03)14410-8\nDewailly, 1997, Definition, clinical manifestations, and prevalance of PCOS, 259\nZacur, 1997, Prolactin abnormalities in PCOS, 287\n2004, The Rotterdam ESHRE\u002FASRM sponsored PCOS consensus workshop group, Hum. Reprod., 19, 41\nBalen, 2003, Ultrasound assessment of the polycystic ovary: international consensus definitions, Hum. Reprod. Update, 9, 505, 10.1093\u002Fhumupd\u002Fdmg044\nForest, 1992, Formes non classiques dites « tardives » du déficit en 21-hydroxylase : diagnostic différentiel avec les hétérozygotes et conseil génétique, Rev. Fr. Endocrinol. Clin., 33, 47\nDewailly, 1997, Pathophysiology and clinical manifestations of nonclassic 21-hydroxylase deficiency, 173\nAzziz, 1997, Idiopathic Hirsutism: definition, prevalence and inheritance, 529\nCortet-Rudelli, 1997, Drug-induced androgen excess, 613\nNelson-DeGrave, 2004, Valproate potentiates androgen biosynthesis in human ovarien theca cells, Endocrinology, 145, 799, 10.1210\u002Fen.2003-0940\nDiamanti-Kandarakis, 1997, Cushing's disease and androgen excess, 569\nDeroubaix-Allard, 1997, Acromegaly and androgen excess, 585\nAzziz, 1997, Diagnosis, screening, and treatment of nonclassic 21-hydroxylase deficiency, 181\nSpritzer, 1990, Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia, J. Clin. Endocrinol. Metab., 70, 642, 10.1210\u002Fjcem-70-3-642\nIbanez, 2004, Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide, J. Clin. Endocrinol. Metab., 89, 4716, 10.1210\u002Fjc.2004-0047\nKorytkowski, 1995, Metabolic effects of oral contraceptives in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 80, 3327, 10.1210\u002Fjc.80.11.3327",{"ES":1146},"Hiperandrogenismo en la adolescente",{"VOID":1148},"10.1016\u002Fs1283-081x(06)46492-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06464924",[1151,1166,1178],{"id":1152,"sortIndex":114,"researcher":26,"roles":1153,"affiliations":1154,"properties":1163},"6cfd7a71-c611-4f3f-bcf0-f2ea5b695550",[696],[1155],{"id":26,"sortIndex":36,"affiliation":1156,"properties":26},{"id":1157,"createTime":1158,"updateTime":1158,"relativeEntities":1159,"slug":26,"properties":1160,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"38c841f4-3384-42fa-b581-8e6f69a378a8","2023-12-12T03:53:07.978+00:00",[],{"title":1161},{"VI":1162},"Service de gynécologie endocrinienne et de médecine de la reproduction, centre hospitalier universitaire de Lille, hôpital Jeanne de Flandre, 2, avenue Oscar-Lambert, 59037 Lille cedex, France",{"title":1164},{"VI":1165},"D. Dewailly",{"id":1167,"sortIndex":115,"researcher":26,"roles":1168,"affiliations":1169,"properties":1175},"5c0b4907-873d-4c44-a4b3-b27503c92a1e",[696],[1170],{"id":26,"sortIndex":36,"affiliation":1171,"properties":26},{"id":1157,"createTime":1158,"updateTime":1158,"relativeEntities":1172,"slug":26,"properties":1173,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1174},{"VI":1162},{"title":1176},{"VI":1177},"S. Jonard",{"id":1179,"sortIndex":36,"researcher":26,"roles":1180,"affiliations":1181,"properties":1187},"200596ea-d35a-46a9-a3c0-ff3aea2f23d5",[696],[1182],{"id":26,"sortIndex":36,"affiliation":1183,"properties":26},{"id":1157,"createTime":1158,"updateTime":1158,"relativeEntities":1184,"slug":26,"properties":1185,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1186},{"VI":1162},{"title":1188},{"VI":1189},"C. Richard",{"url":1149,"publisher":1191,"properties":1199},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1192,"slug":662,"properties":1193,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1196,"manageAffiliations":1197,"indexDatabases":1198,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1194,"title":1195},{"VOID":665},{"EN":667},[],[],[],{"volume":1200,"pages":1202},{"VOID":1201},"42",{"VOID":1055},"2006-01-01",2006,{"id":1206,"createTime":1207,"updateTime":1207,"relativeEntities":1208,"slug":1209,"properties":1210,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1216,"fullTextUrl":26,"authors":1217,"publicationType":747,"publisherRelationship":1466,"citationCount":26,"citationInfo":26,"publishDate":1480,"publishYear":1481,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"1517de81-de0e-4173-bcb4-5f01d1d3395b","2023-12-02T12:30:19.789+00:00",[],"Menopausia",{"references":1211,"title":1213,"doi":1214},{"VOID":1212},"Rousset-Jablonski, 2021, How to diagnose menopause? Postmenopausal women management : CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 318\nHarlow, 2007, Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging, Climacteric, 10, 112, 10.1080\u002F13697130701258838\nRandolph, 2003, Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status, J Clin Endocrinol Metab, 88, 1516, 10.1210\u002Fjc.2002-020777\nRandolph, 2011, Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period, J Clin Endocrinol Metab, 96, 746, 10.1210\u002Fjc.2010-1746\nFreeman, 2007, Association of anti-mullerian hormone levels with obesity in late reproductive-age women, Fertil Steril, 87, 101, 10.1016\u002Fj.fertnstert.2006.05.074\nGracia, 2005, The relationship between obesity and race on inhibin B during the menopause transition, Menopause, 12, 559, 10.1097\u002F01.gme.0000172268.24949.94\nHuddleston, 2010, Racial and ethnic disparities in reproductive endocrinology and infertility, Am J Obstet Gynecol, 202, 413, 10.1016\u002Fj.ajog.2009.12.020\nMaitrot-Mantelet, 2021, Differential diagnosis of vasomotor symptoms. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 329\nPalacios, 2015, Update on management of genitourinary syndrome of menopause: a practical guide, Maturitas, 82, 308, 10.1016\u002Fj.maturitas.2015.07.020\nFaubion, 2017, Genitourinary syndrome of menopause: management strategies for the clinician, Mayo Clin Proc, 92, 1842, 10.1016\u002Fj.mayocp.2017.08.019\nPortman, 2014, Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society, Menopause, 21, 1063, 10.1097\u002FGME.0000000000000329\nNappi, 2016, Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE survey, Climacteric, 19, 188, 10.3109\u002F13697137.2015.1107039\nLegendre, 2012, Urinary incontinence and menopause, Progr Urol, 22, 615, 10.1016\u002Fj.purol.2012.08.267\nGosset, 2021, Menopausal hormone therapy for the management of osteoporosis, Best Pract Res Clin Endocrinol Metab, 35, 10.1016\u002Fj.beem.2021.101551\nGrange L, Chales G, Alliot Launois F. Livre blanc des états généraux de l’ostéoporose 2016.\nPouillès, 2021, Menopause, menopause hormone therapy and osteoporosis. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 420\nBoulat, 2019, Principales évolutions de la mortalité par cause médicale sur la période 2000–2016 en France métropolitaine, Bull Epidemiol Hebd, 576\nLecoffre, 2017, L’accident vasculaire cérébral en France : patients hospitalisés pour AVC en 2014 et évolutions 2008–2014, Bull Epidemiol Hebd, 84\nGabet, 2016, Évolution temporelle du recours à la réadaptation cardiaque après un infarctus du myocarde, France, 2010–2014, Bull Epidemiol Hebd, 43, 764\nPlu-Bureau, 2021, Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 438\nHaute Autorité de santé. Cancer du sein : modalités de dépistage en fonction du risque 2014. www.has-sante.fr\u002Fjcms\u002Fpprd_2974673\u002Ffr\u002Fcancer-du-sein-modalites-specifiques-de-depistage-pour-les-femmes-a-haut-risque#toc_1_1_3.\nDuclos, 2021, Effects of physical activity and decreased sedentary behaviours in menopausal women. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 335\nLaCroix, 2017, The objective physical activity and cardiovascular disease health in older women (OPACH) study, BMC Public Health, 17, 192, 10.1186\u002Fs12889-017-4065-6\nAgence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. Actualisation des repères du PNNS-révision des repères relatifs à l’activité physique et à la sédentarité; 2016.\nInstitut national de la santé et de la recherche médicale. Activité physique : prévention et traitement des maladies chroniques 2019.\nAmbikairajah, 2019, Fat mass changes during menopause: a meta-analysis, Am J Obstet Gynecol, 221, 393, 10.1016\u002Fj.ajog.2019.04.023\nHaute Autorité de santé. Guide de promotion, consultation et prescription médicale d’activité physique et sportive pour la santé chez les adultes 2018. www.has-sante.fr.\nLecerf, 2021, Nutritional advices for postmenopausal woman. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 349\nZiel, 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, N Engl J Med, 293, 1167, 10.1056\u002FNEJM197512042932303\nGrady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326\u002F0003-4819-117-12-1016\nHulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\u002Fprogestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001\u002Fjama.280.7.605\nRossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nChlebowski, 2003, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial, JAMA, 289, 3243, 10.1001\u002Fjama.289.24.3243\nBeral, 2019, Menopausal hormone therapy and 20-year breast cancer mortality, Lancet, 394, 1139, 10.1016\u002FS0140-6736(19)32033-1\nManson, 2013, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials, JAMA, 310, 1353, 10.1001\u002Fjama.2013.278040\nManson, 2017, Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials, JAMA, 318, 927, 10.1001\u002Fjama.2017.11217\nBenkhadra, 2015, Menopausal hormone therapy and mortality: a systematic review and meta-analysis, J Clin Endocrinol Metab, 100, 4021, 10.1210\u002Fjc.2015-2238\nHa-Vinh, 2010, Individual factors and mortality associated with hormone replacement therapy in a French cohort of women from 60 to 69 years of age, J Gynecol Obstet Biol Reprod (Paris), 39, 453, 10.1016\u002Fj.jgyn.2010.06.006\nBoardman HM, Hartley L, Eisinga A, Main C, Figuls MR i, Cosp XB, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;3:CD002229. Doi: 10.1002\u002F14651858.CD002229.pub4.\nSimin, 2017, Menopausal hormone therapy and cancer risk: an overestimated risk?, Eur J Cancer Oxf Engl, 84, 60, 10.1016\u002Fj.ejca.2017.07.012\nAnderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001\u002Fjama.291.14.1701\nCanonico, 2016, Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen, Stroke, 47, 1734, 10.1161\u002FSTROKEAHA.116.013052\nRovinski, 2018, Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis, Thromb Res, 168, 83, 10.1016\u002Fj.thromres.2018.06.014\nVinogradova, 2020, Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases, BMJ, 371, m3873, 10.1136\u002Fbmj.m3873\nCanonico, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study, Circulation, 115, 840, 10.1161\u002FCIRCULATIONAHA.106.642280\nCanonico, 2010, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study, Arterioscler Thromb Vasc Biol, 30, 340, 10.1161\u002FATVBAHA.109.196022\nScarabin, 2018, Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis, Climacteric, 21, 341, 10.1080\u002F13697137.2018.1446931\nCurb, 2006, Venous thrombosis and conjugated equine estrogen in women without a uterus, Arch Intern Med, 166, 772, 10.1001\u002Farchinte.166.7.772\nCushman, 2004, Estrogen plus progestin and risk of venous thrombosis, JAMA, 292, 1573, 10.1001\u002Fjama.292.13.1573\nCanonico, 2006, Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study, J Thromb Haemost, 4, 1259, 10.1111\u002Fj.1538-7836.2006.01933.x\nSweetland, 2012, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, J Thromb Haemost, 10, 2277, 10.1111\u002Fj.1538-7836.2012.04919.x\nVinogradova, 2019, Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases, BMJ, 364, k4810, 10.1136\u002Fbmj.k4810\nPoudou, 2021, Benefit-risk balance of hormone replacement therapy: cancers and mortality. Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 462\nFournier, 2014, Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort, Breast Cancer Res Treat, 145, 535, 10.1007\u002Fs10549-014-2934-6\nCordina-Duverger, 2013, Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France, PloS One, 8, 10.1371\u002Fjournal.pone.0078016\nBeral, 2011, Breast cancer risk in relation to the interval between menopause and starting hormone therapy, J Natl Cancer Inst, 103, 296, 10.1093\u002Fjnci\u002Fdjq527\nBeral, 2003, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016\u002FS0140-6736(03)14065-2\nCollins, 2005, Breast cancer risk with postmenopausal hormonal treatment, Hum Reprod Update, 11, 545, 10.1093\u002Fhumupd\u002Fdmi028\nGrady, 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis, Obstet Gynecol, 85, 304, 10.1016\u002F0029-7844(94)00383-O\nAllen, 2010, Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition, Am J Epidemiol, 172, 1394, 10.1093\u002Faje\u002Fkwq300\nBrinton, 2014, Menopausal hormone therapy and risk of endometrial cancer, J Steroid Biochem Mol Biol, 142, 83, 10.1016\u002Fj.jsbmb.2013.05.001\nBeresford, 1997, Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women, Lancet, 349, 458, 10.1016\u002FS0140-6736(96)07365-5\nJaakkola, 2009, Endometrial cancer in postmenopausal women using estradiol-progestin therapy, Obstet Gynecol, 114, 1197, 10.1097\u002FAOG.0b013e3181bea950\nFournier, 2014, Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008, Am J Epidemiol, 180, 508, 10.1093\u002Faje\u002Fkwu146\nLiu, 2019, Menopausal hormone replacement therapy and the risk of ovarian cancer: a meta-analysis, Front Endocrinol (Lausanne), 10, 801, 10.3389\u002Ffendo.2019.00801\nAvis, 2015, Duration of menopausal vasomotor symptoms over the menopause transition, JAMA Intern Med, 175, 531, 10.1001\u002Fjamainternmed.2014.8063\nRaccah-Tebeka, 2021, Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 373\nRance, 2013, Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes, Front Neuroendocrinol, 34, 211, 10.1016\u002Fj.yfrne.2013.07.003\nPrague, 2017, Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial, Lancet, 389, 1809, 10.1016\u002FS0140-6736(17)30823-1\nGosset, 2021, Menopause hormone treatment in practice. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 358\nDepypere, 2015, The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review, Climacteric, 18, 470, 10.3109\u002F13697137.2014.991302\nRaudaskoski, 2002, Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response, BJOG, 109, 136\nTrémollieres, 2021, Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (short version), Gynecol Obstet Fertil Senol, 49, 305\nHaimov-Kochman, 2006, Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study, Menopause, 13, 370\nAslan, 2007, How best is to discontinue postmenopausal hormone therapy: immediate or tapered?, Maturitas, 56, 78, 10.1016\u002Fj.maturitas.2006.06.006\nLindh-Astrand, 2010, A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms, Menopause, 17, 72, 10.1097\u002Fgme.0b013e3181b397c7\nPerrone, 2013, Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up, Gynecol Obstet Invest, 76, 38, 10.1159\u002F000351104\nMaclennan, 2004, Oral oestrogen and combined oestrogen\u002Fprogestogen therapy versus placebo for hot flushes, Cochrane Database Syst Rev, 4\nDesmarais, 2010, Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions, Maturitas, 67, 296, 10.1016\u002Fj.maturitas.2010.08.005\nHenry, 2008, Drug interactions and pharmacogenomics in the treatment of breast cancer and depression, Am J Psychiatry, 165, 1251, 10.1176\u002Fappi.ajp.2008.08040482\nLethaby, 2013, Phytoestrogens for menopausal vasomotor symptoms, Cochrane Database Syst Rev, 12, CD001395\nSrisukho, 2019, The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue, Int Urogynecol J, 30, 1843, 10.1007\u002Fs00192-019-03991-0\nSzymański, 2018, Genitourinary syndrome of menopause – is the problem solved? State of the art 2018, Prz Menopauzalny, 17, 168\nCastelo-Branco, 2005, Management of post-menopausal vaginal atrophy and atrophic vaginitis, Maturitas, 52, S46, 10.1016\u002Fj.maturitas.2005.06.014\nPinkerton, 2017, Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning, Maturitas, 100, 57, 10.1016\u002Fj.maturitas.2017.03.315\nBachmann, 2000, Diagnosis and treatment of atrophic vaginitis, Am Fam Physician, 61, 3090\nKarakoç, 2019, Genitourinary syndrome of menopause: effects on related factors, quality of life, and self-care power, Prz Menopauzalny, 18, 15\nPastore, 2004, Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative, Maturitas, 49, 292, 10.1016\u002Fj.maturitas.2004.06.019\nMac Bride, 2010, Vulvovaginal atrophy, Mayo Clin Proc, 85, 87, 10.4065\u002Fmcp.2009.0413\nCardozo, 1998, Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee, Obstet Gynecol, 92, 722\nBarnabei, 2005, Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative, Obstet Gynecol, 105, 1063, 10.1097\u002F01.AOG.0000158120.47542.18\nFantl, 1996, Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group, Obstet Gynecol, 88, 745, 10.1016\u002F0029-7844(96)00281-5\nRufford, 2003, A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women, Int Urogynecol J Pelvic Floor Dysfunct, 14, 78, 10.1007\u002Fs00192-003-1054-3\nSteinauer, 2005, Postmenopausal hormone therapy: does it cause incontinence?, Obstet Gynecol, 106, 940, 10.1097\u002F01.AOG.0000180394.08406.15\nHendrix, 2005, Effects of estrogen with and without progestin on urinary incontinence, JAMA, 293, 935, 10.1001\u002Fjama.293.8.935\nWaetjen, 2005, The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women, Obstet Gynecol, 106, 946, 10.1097\u002F01.AOG.0000182576.48290.6d\nSulaica, 2016, Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy, Breast Cancer Res Treat, 157, 203, 10.1007\u002Fs10549-016-3827-7\nMaris, 2021, Management of vulvovaginal atrophy: Physical therapies. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 414\nGambacciani, 2015, Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause, Climacteric, 18, 757, 10.3109\u002F13697137.2015.1045485\nGaspar, 2017, Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause, Lasers Surg Med, 49, 160, 10.1002\u002Flsm.22569\nCruz, 2018, Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women, Menopause, 25, 21, 10.1097\u002FGME.0000000000000955\nRuanphoo, 2020, Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial, Menopause, 27, 858, 10.1097\u002FGME.0000000000001542\nJha, 2019, The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis, Clin Breast Cancer, 19, e556, 10.1016\u002Fj.clbc.2019.04.007\nPreti, 2019, The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS\u002FISSVD best practice consensus document, J Low Genit Tract Dis, 23, 151, 10.1097\u002FLGT.0000000000000462\nKanis, 2005, Assessment of fracture risk, Osteoporos Int, 16, 581, 10.1007\u002Fs00198-004-1780-5\nSornay-Rendu, 2014, How to predict fragility fracture beyond 10 years? The OFELY study, J Clin Endocrinol Metab, 99, 4690, 10.1210\u002Fjc.2014-2601\nLeslie, 2011, A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world, Curr Osteoporos Rep, 9, 129, 10.1007\u002Fs11914-011-0060-5\nBriot, 2018, 2018 update of French recommendations on the management of postmenopausal osteoporosis, Joint Bone Spine, 85, 519, 10.1016\u002Fj.jbspin.2018.02.009\nHaute Autorité de santé. Les médicaments de l’ostéoporose 2019.\nRiggs, 2004, Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites, J Bone Miner Res, 19, 1945, 10.1359\u002Fjbmr.040916\nSowers, 2013, Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity, J Clin Endocrinol Metab, 98, 2854, 10.1210\u002Fjc.2012-4113\nGRIO. Actualisation 2017 des recommandations de traitement de l’ostéoporosepost ménopausique 2017. www.grio.org\u002Fdocuments\u002Fpage240\u002Frecommandations-pmo-actualisation-2017.pdf.\nWeiss, 1999, A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group, Obstet Gynecol, 94, 330\nDelmas, 1999, A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group, Bone, 24, 517, 10.1016\u002FS8756-3282(99)00076-9\nHeikkinen, 2000, Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens, Osteoporos Int, 11, 929, 10.1007\u002Fs001980070031\nGartlehner, 2017, Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US Preventive Services Task Force, JAMA, 318, 2234, 10.1001\u002Fjama.2017.16952\nBanks, 2004, Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women, JAMA, 291, 2212, 10.1001\u002Fjama.291.18.2212\nWasnich, 2004, Changes in bone density and turnover after alendronate or estrogen withdrawal, Menopause, 11, 622, 10.1097\u002F01.GME.0000123641.76105.B5\nGallagher, 2002, Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers, J Clin Endocrinol Metab, 87, 4914, 10.1210\u002Fjc.2002-020727\nHocké, 2021, Syndrome génito-urinaire de la ménopause (SGUM). RPC les femmes ménopausées du CNGOF et du GEMVi, Gynecol Obstr Fertil Senol, 49, 394",{"ES":1209},{"VOID":1215},"10.1016\u002Fs1283-081x(23)47976-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X23479763",[1218,1233,1245,1257,1269,1281,1293,1305,1317,1329,1346,1358,1370,1382,1394,1406,1418,1430,1442,1454],{"id":1219,"sortIndex":135,"researcher":26,"roles":1220,"affiliations":1221,"properties":1230},"ff39c540-6905-45c7-ba30-f671547b2723",[696],[1222],{"id":26,"sortIndex":36,"affiliation":1223,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1226,"slug":26,"properties":1227,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6c598c7e-c70e-4873-95d3-10c61b40e56a","2023-12-02T12:30:19.889+00:00",[],{"title":1228},{"VI":1229},"Collège national des gynécologues et obstétriciens français, Groupe d’étude sur la ménopause et le vieillissement hormonal, Groupe de travail « Recommandation pour la pratique Clinique 2021: les femmes ménopausées », Paris, France",{"title":1231},{"VI":1232},"J.-M. Pouille",{"id":1234,"sortIndex":51,"researcher":26,"roles":1235,"affiliations":1236,"properties":1242},"716f2bd8-4a87-4c40-aaba-8ed515a100e8",[696],[1237],{"id":26,"sortIndex":36,"affiliation":1238,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1239,"slug":26,"properties":1240,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1241},{"VI":1229},{"title":1243},{"VI":1244},"N. Hamdaoui",{"id":1246,"sortIndex":53,"researcher":26,"roles":1247,"affiliations":1248,"properties":1254},"db0da6bd-a139-4ccc-ab33-5d353c7a1b2e",[696],[1249],{"id":26,"sortIndex":36,"affiliation":1250,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1251,"slug":26,"properties":1252,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1253},{"VI":1229},{"title":1255},{"VI":1256},"J. Hugon-Rodin",{"id":1258,"sortIndex":298,"researcher":26,"roles":1259,"affiliations":1260,"properties":1266},"6d30f934-d7f9-4283-9612-ac3aba3cfb0e",[696],[1261],{"id":26,"sortIndex":36,"affiliation":1262,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1263,"slug":26,"properties":1264,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1265},{"VI":1229},{"title":1267},{"VI":1268},"G. André",{"id":1270,"sortIndex":162,"researcher":26,"roles":1271,"affiliations":1272,"properties":1278},"601a1d29-553e-4a98-a5c5-7423aac86e0e",[696],[1273],{"id":26,"sortIndex":36,"affiliation":1274,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1275,"slug":26,"properties":1276,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1277},{"VI":1229},{"title":1279},{"VI":1280},"M. Duclos",{"id":1282,"sortIndex":173,"researcher":26,"roles":1283,"affiliations":1284,"properties":1290},"adb5c12d-9967-4da2-ae28-90f05034e0fe",[696],[1285],{"id":26,"sortIndex":36,"affiliation":1286,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1287,"slug":26,"properties":1288,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1289},{"VI":1229},{"title":1291},{"VI":1292},"X. Fritel",{"id":1294,"sortIndex":234,"researcher":26,"roles":1295,"affiliations":1296,"properties":1302},"48101ac1-40be-472b-979e-d0c0e14b44b2",[696],[1297],{"id":26,"sortIndex":36,"affiliation":1298,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1299,"slug":26,"properties":1300,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1301},{"VI":1229},{"title":1303},{"VI":1304},"O. Graesslin",{"id":1306,"sortIndex":336,"researcher":26,"roles":1307,"affiliations":1308,"properties":1314},"263ebcd7-675f-479a-b53d-d03642cb5a95",[696],[1309],{"id":26,"sortIndex":36,"affiliation":1310,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1311,"slug":26,"properties":1312,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1313},{"VI":1229},{"title":1315},{"VI":1316},"C. Mathelin",{"id":1318,"sortIndex":158,"researcher":26,"roles":1319,"affiliations":1320,"properties":1326},"527bbe33-b750-4d3c-b958-7a4a44069cd1",[696],[1321],{"id":26,"sortIndex":36,"affiliation":1322,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1323,"slug":26,"properties":1324,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1325},{"VI":1229},{"title":1327},{"VI":1328},"A. Gosset",{"id":1330,"sortIndex":36,"researcher":26,"roles":1331,"affiliations":1332,"properties":1343},"1778a412-5429-47f6-b380-130f2196a836",[696],[1333],{"id":26,"sortIndex":36,"affiliation":1334,"properties":26},{"id":1335,"createTime":1336,"updateTime":1337,"relativeEntities":1338,"slug":1339,"properties":1340,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0523ed73-f6f8-4b89-9ae5-2f5e91940931","2023-12-02T12:30:19.804+00:00","2025-06-11T18:20:31.093+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-m%C3%A9decine-de-la-reproduction-H%C3%B4pital-Tenon-AP-HP-Sorbonne-Universit%C3%A9-4-rue-de-la-Chine-75020-Paris-France",{"title":1341},{"VI":1342},"Service de gynécologie obstétrique médecine de la reproduction, Hôpital Tenon, AP–HP, Sorbonne Université, 4 rue de la Chine, 75020 Paris, France",{"title":1344},{"VI":1345},"N. Chabbert-Buffet",{"id":1347,"sortIndex":59,"researcher":26,"roles":1348,"affiliations":1349,"properties":1355},"a16e47f4-64e1-414f-96f9-f8b4be1318e1",[696],[1350],{"id":26,"sortIndex":36,"affiliation":1351,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1352,"slug":26,"properties":1353,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1354},{"VI":1229},{"title":1356},{"VI":1357},"C. Rousset-Jablonski",{"id":1359,"sortIndex":124,"researcher":26,"roles":1360,"affiliations":1361,"properties":1367},"2df716cb-0ba4-4e19-afa4-b9f7208f1bad",[696],[1362],{"id":26,"sortIndex":36,"affiliation":1363,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1364,"slug":26,"properties":1365,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1366},{"VI":1229},{"title":1368},{"VI":1369},"P. Lopes",{"id":1371,"sortIndex":116,"researcher":26,"roles":1372,"affiliations":1373,"properties":1379},"d04c02cd-1fab-4835-b3b9-dc4fccecd5d5",[696],[1374],{"id":26,"sortIndex":36,"affiliation":1375,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1376,"slug":26,"properties":1377,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1378},{"VI":1229},{"title":1380},{"VI":1381},"E. Maris",{"id":1383,"sortIndex":114,"researcher":26,"roles":1384,"affiliations":1385,"properties":1391},"4db97be7-9be9-4075-b6e0-4c5b6a374750",[696],[1386],{"id":26,"sortIndex":36,"affiliation":1387,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1388,"slug":26,"properties":1389,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1390},{"VI":1229},{"title":1392},{"VI":1393},"G. Plu-Bureau",{"id":1395,"sortIndex":111,"researcher":26,"roles":1396,"affiliations":1397,"properties":1403},"8329402b-35cf-4eb6-b7dd-aa8527e8ee2a",[696],[1398],{"id":26,"sortIndex":36,"affiliation":1399,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1400,"slug":26,"properties":1401,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1402},{"VI":1229},{"title":1404},{"VI":1405},"J.-M. Lecerf",{"id":1407,"sortIndex":115,"researcher":26,"roles":1408,"affiliations":1409,"properties":1415},"7267bb95-824a-475c-bf1c-9773b9a59886",[696],[1410],{"id":26,"sortIndex":36,"affiliation":1411,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1412,"slug":26,"properties":1413,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1414},{"VI":1229},{"title":1416},{"VI":1417},"F. Trémollieres",{"id":1419,"sortIndex":356,"researcher":26,"roles":1420,"affiliations":1421,"properties":1427},"20d4868c-d9e8-4eae-bd04-032e8f16942e",[696],[1422],{"id":26,"sortIndex":36,"affiliation":1423,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1424,"slug":26,"properties":1425,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1426},{"VI":1229},{"title":1428},{"VI":1429},"G. Robin",{"id":1431,"sortIndex":103,"researcher":26,"roles":1432,"affiliations":1433,"properties":1439},"831a096c-14b8-429b-97de-3fcf4b95f1b5",[696],[1434],{"id":26,"sortIndex":36,"affiliation":1435,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1436,"slug":26,"properties":1437,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1438},{"VI":1229},{"title":1440},{"VI":1441},"L. Maitrot-Mantelet",{"id":1443,"sortIndex":50,"researcher":26,"roles":1444,"affiliations":1445,"properties":1451},"44247774-6183-48ef-9860-738229f683b6",[696],[1446],{"id":26,"sortIndex":36,"affiliation":1447,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1448,"slug":26,"properties":1449,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1450},{"VI":1229},{"title":1452},{"VI":1453},"G. Boutet",{"id":1455,"sortIndex":52,"researcher":26,"roles":1456,"affiliations":1457,"properties":1463},"c151b938-5903-41bb-ac5c-c59a7172515b",[696],[1458],{"id":26,"sortIndex":36,"affiliation":1459,"properties":26},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1460,"slug":26,"properties":1461,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1462},{"VI":1229},{"title":1464},{"VI":1465},"C. Hocké",{"url":1216,"publisher":1467,"properties":1475},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1468,"slug":662,"properties":1469,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1472,"manageAffiliations":1473,"indexDatabases":1474,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1470,"title":1471},{"VOID":665},{"EN":667},[],[],[],{"volume":1476,"pages":1478},{"VOID":1477},"59",{"VOID":1479},"1-13","2023-09-01",2023,{"id":1483,"createTime":1484,"updateTime":1484,"relativeEntities":1485,"slug":1486,"properties":1487,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1494,"fullTextUrl":26,"authors":1495,"publicationType":747,"publisherRelationship":1541,"citationCount":26,"citationInfo":26,"publishDate":1554,"publishYear":1555,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a1761522-6120-48d3-bcb7-4a62c847c458","2023-11-30T06:21:53.407+00:00",[],"F%C3%A1rmacos-tocol%C3%ADticos",{"references":1488,"title":1490,"doi":1492},{"VOID":1489},"Sentilhes, 2016, Recommandations pour la pratique clinique : prévention de la prématurité spontanée et de ses conséquences (hors rupture des membranes) –Texte des recommandations, J Gynecol Obstet Biol Reprod, 45, 1446, 10.1016\u002Fj.jgyn.2016.09.011\nDoret, 2016, La tocolyse en cas de menace d’accouchement prématuré à membranes intactes, J Gynecol Obstet Biol Reprod, 45, 1374, 10.1016\u002Fj.jgyn.2016.09.018\nNeilson, 2014, Betamimetics for inhibiting preterm labour, Cochrane Database Syst Rev, CD004352\nHaas, 2012, Tocolytic therapy for preterm delivery: systematic review and network meta-analysis, BMJ, 345, e6226, 10.1136\u002Fbmj.e6226\nFlenady, 2014, Oxytocin receptor antagonists for inhibiting preterm labour, Cochrane Database Syst Rev, CD004452\nHaas, 2009, Tocolytic therapy: a meta-analysis and decision analysis, Obstet Gynecol, 113, 585, 10.1097\u002FAOG.0b013e318199924a\nConde-Agudelo, 2011, Nifedipine in the management of preterm labor: a systematic review and meta-analysis, Am J Obstet Gynecol, 204, 10.1016\u002Fj.ajog.2010.11.038\nTsatsaris, 2001, Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis, Obstet Gynecol, 97, 840\nCoomarasamy, 2002, Oxytocin antagonists for tocolysis in preterm labour -- a systematic review, Med Sci Monit, 8, RA268\nLeveno, 1986, Single-centre randomised trial of ritodrine hydrochloride for preterm labour, Lancet, 1, 1293, 10.1016\u002FS0140-6736(86)91219-5\nde Heus, 2009, Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study, BMJ, 338, b744, 10.1136\u002Fbmj.b744\nMabie, 1983, Pulmonary edema induced by betamimetic drugs, South Med J, 76, 1354, 10.1097\u002F00007611-198311000-00007\nDudenhausen, 2006, “Normal” pregnancy with adverse events on initial tocolytic treatment, BJOG, 113, 116, 10.1111\u002Fj.1471-0528.2006.01138.x\nPaternoster, 2004, Maternal complications from tocolytic treatment with ritodrine. Three cases of pulmonary edema, Minerva Ginecol, 56, 491\nKaraman, 2004, Pulmonary edema after ritodrine therapy during pregnancy and subsequent cesarean section with epidural anesthesia, Clin Exp Obstet Gynecol, 31, 67\nHamel, 2002, [Pulmonary edema and tocolysis with beta-agonists], Rev Mal Respir, 19, 241\nMilos, 1988, Maternal pulmonary edema complicating beta-adrenergic therapy of preterm labor, AJR Am J Roentgenol, 151, 917, 10.2214\u002Fajr.151.5.917\nEvron, 1983, [Pulmonary edema occurring after isoxsuprine treatment for preterm labor], Harefuah, 105, 287\nBenedetti, 1982, Maternal pulmonary edema during premature labor inhibition, Obstet Gynecol, 59\nStubblefield, 1978, Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor: a case report, Am J Obstet Gynecol, 132, 341, 10.1016\u002F0002-9378(78)90907-9\nNagey, 1982, Pulmonary complications of isoxsuprine therapy in the gravida, Obstet Gynecol, 59\nJacobs, 1980, Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy, Obstet Gynecol, 56, 56\nGuernsey, 1981, Pulmonary edema associated with the use of betamimetic agents in preterm labor, Am J Hosp Pharm, 38, 1942\nBrosset, 1982, Cardiac complications of ritodrine in mother and baby, Lancet, 1, 1468, 10.1016\u002FS0140-6736(82)92476-X\nCarson, 2002, Atrial fibrillation in pregnancy associated with oral terbutaline, Obstet Gynecol, 100, 1096\nAbramovici, 1980, Maternal pulmonary edema occurring after therapy with ritodrine for premature uterine contractions, Acta Obstet Gynecol Scand, 59, 555, 10.3109\u002F00016348009155450\nDordević, 2002, [Successful resuscitation of a patient with prolonged tocolytic therapy and an emergency cesarean section], Vojnosanit Pregl, 59, 325, 10.2298\u002FVSP0203325D\nMagnus, 1987, [Myocardial infarction during tocolysis with sympathomimetics], Tidsskr Nor Laegeforen, 107, 943\nKotoujansky, 1985, [Tocolysis using salbutamol in cases of cardiac rhythm disorders in the mother. Apropos of 4 cases], J Gynecol Obstet Biol Reprod, 14, 915\nZhang, 2014, Ritodrine-induced agranulocytosis in pregnancy, J Obstet Gynaecol, 34, 533, 10.3109\u002F01443615.2014.914481\nYasuda, 2012, Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms, J Obstet Gynaecol Res, 38, 574, 10.1111\u002Fj.1447-0756.2011.01756.x\nKikkawa, 2008, Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia, J Obstet Gynaecol Res, 34, 286, 10.1111\u002Fj.1447-0756.2008.00773.x\nMuro, 1991, Ritodrine-induced agranulocytosis, Int J Gynaecol Obstet, 36, 329, 10.1016\u002F0020-7292(91)90488-Q\nVerriello, 2009, Rhabdomyolysis caused by tocolytic therapy with ritodrine hydrochloride, Neuromuscul Disord, 19, 718, 10.1016\u002Fj.nmd.2009.06.364\nNasu, 2006, Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy, Gynecol Obstet Invest, 1, 53, 10.1159\u002F000088531\nRosene, 1982, Cerebral ischemia associated with parenteral terbutaline use in pregnant migraine patients, Am J Obstet Gynecol, 143, 405, 10.1016\u002F0002-9378(82)90081-3\nHudgens, 1993, Sudden death associated with terbutaline sulfate administration, Am J Obstet Gynecol, 169, 120, 10.1016\u002F0002-9378(93)90144-8\nMilliez, 1980, A case report of maternal death associated with betamimetics and betamethasone administration in premature labor, Eur J Obstet Gynecol Reprod Biol, 11, 95, 10.1016\u002F0028-2243(80)90014-3\nRäsänen, 1990, The effects of ritodrine infusion on fetal myocardial function and fetal hemodynamics, Acta Obstet Gynecol Scand, 69, 487, 10.3109\u002F00016349009013323\nGokay, 2001, Changes in fetal hemodynamics with ritodrine tocolysis, Ultrasound Obstet Gynecol, 18, 44, 10.1046\u002Fj.1469-0705.2001.00453.x\nBrar, 1988, Maternal and fetal blood flow velocity waveforms in patients with preterm labor: effect of tocolytics, Obstet Gynecol, 72, 209\nWitter, 2009, In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes, Am J Obstet Gynecol, 201, 553, 10.1016\u002Fj.ajog.2009.07.010\nConnors, 2005, Beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins, J Child Neurol, 20, 876, 10.1177\u002F08830738050200110401\nPitzer, 2001, Child development after maternal tocolysis with beta-sympathomimetic drugs, Child Psychiatry Hum Dev, 31, 165, 10.1023\u002FA:1026419720410\nHadders-Algra, 1986, Long-term follow-up of children prenatally exposed to ritodrine, Br J Obstet Gynaecol, 93, 156, 10.1111\u002Fj.1471-0528.1986.tb07880.x\nFreysz, 1977, A long term evaluation of infants who received a beta-mimetic drug while in utero, J Perinat Med, 5, 94, 10.1515\u002Fjpme.1977.5.2.94\nGidaya, 2016, In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders, Pediatrics, 137, e20151316, 10.1542\u002Fpeds.2015-1316\nNICE. Preterm Labour and Birth [Internet]. London: National Institute for Health and Care Excellence (UK); 2015.\nRomero, 2000, An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue, Am J Obstet Gynecol, 182, 1173, 10.1067\u002Fmob.2000.95834\nvan Vliet, 2016, Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial, Lancet, 387, 2117, 10.1016\u002FS0140-6736(16)00548-1\nAl-Omari, 2006, Atosiban and nifedipine in acute tocolysis: a comparative study, Eur J Obstet Gynecol Reprod Biol, 128, 129, 10.1016\u002Fj.ejogrb.2005.12.010\nSalim, 2012, Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial, Obstet Gynecol, 120, 1323, 10.1097\u002FAOG.0b013e3182755dff\nSeinen, 2013, [Maternal pulmonary oedema due to the use of atosiban in cases of multiple gestation], Ned Tijdschr Geneeskd, 157, A5316\nFernández, 2011, Severe non-cardiogenic pulmonary oedema secondary to atosiban and steroids, Int J Obstet Anesth, 20, 189, 10.1016\u002Fj.ijoa.2010.09.003\nFerguson, 1990, A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome, Am J Obstet Gynecol, 163, 105, 10.1016\u002FS0002-9378(11)90679-6\nSilberschmidt, 2008, Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis, BJOG, 115, 480, 10.1111\u002Fj.1471-0528.2007.01630.x\nClouqueur, 2015, [Adverse effects of calcium channels blockers used as tocolytic treatment], J Gynecol Obstet Biol Reprod, 44, 341, 10.1016\u002Fj.jgyn.2014.12.012\nFlenady, 2014, Calcium channel blockers for inhibiting preterm labour and birth, Cochrane Database Syst Rev, CD002255\nAra, 2008, A prospective randomised trial of nifedipine versus placebo in preterm labour, Bangladesh J Obstet Gynaecol, 23, 61, 10.3329\u002Fbjog.v23i2.4962\nZhang, 2002, [Clinical observations on the prevention and treatment of premature labor with nifedipine], Hua Xi Yi Ke Da Xue Xue Bao, 33, 288\nBejan-Angoulvant, 2015, [Calcium channel blockers pharmacology and their use as tocolytics], J Gynecol Obstet Biol Reprod, 44, 305, 10.1016\u002Fj.jgyn.2014.12.010\nParant, 2015, [Use of calcium channel blockers (CCB) for tocolysis in France and abroad], J Gynecol Obstet Biol Reprod, 44, 312, 10.1016\u002Fj.jgyn.2014.12.016\nLe Ray, 2010, [Nifedipine or nicardipine in management of threatened preterm delivery: an observational population-based study], J Gynecol Obstet Biol Reprod, 39, 490, 10.1016\u002Fj.jgyn.2010.04.004\nLaas, 2012, [Comparison of the rate of maternal complications of nifedipine and nicardipine in cases of preterm labor: historical study on two consecutive periods], J Gynecol Obstet Biol Reprod, 41, 631, 10.1016\u002Fj.jgyn.2012.04.020\nMcGuirl J, Arzuaga B, Lee BH. Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants. Pediatr Cardiol 2012;33:60–4.\nSmith, 2007, Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor, Am J Obstet Gynecol, 196, 10.1016\u002Fj.ajog.2006.10.868\nHaghighi, 2005, Isosorbide dinitrate for treatment of preterm labor, Int J Gynaecol Obstet, 89, 274, 10.1016\u002Fj.ijgo.2005.03.004\nDuckitt, 2014, Nitric oxide donors for treating preterm labour, Cochrane Database Syst Rev, CD002860\nAmorim, 2009, [Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial], Rev Bras Ginecol Obstet, 31, 552\nCrowther, 2014, Magnesium sulphate for preventing preterm birth in threatened preterm labour, Cochrane Database Syst Rev, CD001060\nReinebrant, 2015, Cyclo-oxygenase (COX) inhibitors for treating preterm labour, Cochrane Database Syst Rev, CD001992\nErny, 1986, The effects of oral administration of progesterone for premature labor, Am J Obstet Gynecol, 154, 525, 10.1016\u002F0002-9378(86)90595-8\nChawanpaiboon, 2011, Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor, J Obstet Gynaecol Res, 37, 787, 10.1111\u002Fj.1447-0756.2010.01434.x\nSu, 2014, Progestational agents for treating threatened or established preterm labour, Cochrane Database Syst Rev, CD006770\nKCE. Prévention de l’accouchement prématuré chez les femmes à risque – Évaluation de quelques mesures courantes. https:\u002F\u002Fkce.fgov.be\u002Ffr\u002Fpr%C3%A9vention-de-l%E2%80%99accouchement-pr%C3%A9matur%C3%A9-chez-les-femmes-%C3%A0-risque-%E2%80%93-evaluation-de-quelques-mesures.\n[No authors listed]. Practice Bulletin No. 159: Management of Preterm Labor. Obstet Gynecol 2016;127:e29–38.\nOrganisation mondiale de la santé. Recommandations de l’OMS sur les interventions visant à améliorer l’issue des naissances prématurées. Août 2015. http:\u002F\u002Fapps.who.int\u002Firis\u002Fbitstream\u002F10665\u002F200219\u002F1\u002FWHO_RHR_15.16_fre.pdf?ua=1.\nVeille, 1985, Maternal cardiovascular adaptations to twin pregnancy, Am J Obstet Gynecol, 153, 261, 10.1016\u002FS0002-9378(85)80109-5\nDodd, 2012, Oral betamimetics for maintenance therapy after threatened preterm labour, Cochrane Database Syst Rev, 12, CD003927\nChawanpaiboon, 2014, Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes, Cochrane Database Syst Rev, CD010800\nHan, 2013, Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD000940\nNaik Gaunekar, 2013, Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD004071\nRoos, 2013, Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial, JAMA, 309, 41, 10.1001\u002Fjama.2012.153817\nParry, 2014, The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour, Aust N Z J Obstet Gynaecol, 54, 231, 10.1111\u002Fajo.12179\nPapatsonis, 2013, Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD005938\nVogel, 2014, Combination of tocolytic agents for inhibiting preterm labour, Cochrane Database Syst Rev, CD006169\nManuck, 2015, Tocolysis for women with early spontaneous preterm labor and advanced cervical dilation, Obstet Gynecol, 126, 954, 10.1097\u002FAOG.0000000000001095\nde Veciana, 1995, Tocolysis in advanced preterm labor: impact on neonatal outcome, Am J Perinatol, 12, 294, 10.1055\u002Fs-2007-994478\nAmon, 2000, Tocolysis with advanced cervical dilatation, Obstet Gynecol, 95, 358\nKlauser, 2016, Tocolysis in women with advanced preterm labor: a secondary analysis of a randomized clinical trial, J Matern Fetal Neonatal Med, 29, 696, 10.3109\u002F14767058.2015.1018171",{"ES":1491},"Fármacos tocolíticos",{"VOID":1493},"10.1016\u002Fs1283-081x(19)42003-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X19420031",[1496,1511,1526],{"id":1497,"sortIndex":36,"researcher":26,"roles":1498,"affiliations":1499,"properties":1508},"b43820b1-e054-4ee3-ac76-3d9ee61394fc",[696],[1500],{"id":26,"sortIndex":36,"affiliation":1501,"properties":26},{"id":1502,"createTime":1503,"updateTime":1503,"relativeEntities":1504,"slug":26,"properties":1505,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"28f2c27d-a0a5-47ac-889a-e2fbc3dcd77a","2023-11-30T06:21:53.446+00:00",[],{"title":1506},{"VI":1507},"Service de gynécologie obstétrique, Hôpital Femme-Mère-Enfant, Hospices civils de Lyon, 59, boulevard Pinel, 69677 Bron cedex, France",{"title":1509},{"VI":1510},"M. Doret",{"id":1512,"sortIndex":115,"researcher":26,"roles":1513,"affiliations":1514,"properties":1523},"5319dc5e-c1f6-44cb-b32a-142b758b5503",[696],[1515],{"id":26,"sortIndex":36,"affiliation":1516,"properties":26},{"id":1517,"createTime":1518,"updateTime":1518,"relativeEntities":1519,"slug":26,"properties":1520,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"20b165d4-879a-440b-aff8-f3bb9f981f1d","2023-11-30T06:21:53.467+00:00",[],{"title":1521},{"VI":1522},"Service de gynécologie-obstétrique, Hôpital Trousseau, AP–HP, Paris, France",{"title":1524},{"VI":1525},"G. Kayem",{"id":1527,"sortIndex":114,"researcher":26,"roles":1528,"affiliations":1529,"properties":1538},"112b2d8a-62db-4ba9-8b3a-0c80b10d7b98",[696],[1530],{"id":26,"sortIndex":36,"affiliation":1531,"properties":26},{"id":1532,"createTime":1533,"updateTime":1533,"relativeEntities":1534,"slug":26,"properties":1535,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4c570d3a-0ed7-4288-ab4e-2ec370f4f17a","2023-11-30T06:21:53.515+00:00",[],{"title":1536},{"VI":1537},"Service de gynécologie-obstétrique, Hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France",{"title":1539},{"VI":1540},"L. Sentilhes",{"url":1494,"publisher":1542,"properties":1550},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1543,"slug":662,"properties":1544,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1547,"manageAffiliations":1548,"indexDatabases":1549,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1545,"title":1546},{"VOID":665},{"EN":667},[],[],[],{"volume":1551,"pages":1553},{"VOID":1552},"55",{"VOID":1055},"2019-06-01",2019,{"id":1557,"createTime":1558,"updateTime":1559,"relativeEntities":1560,"slug":1561,"properties":1562,"entityType":688,"verifyStatus":25,"verifyTime":1559,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1569,"fullTextUrl":26,"authors":1570,"publicationType":747,"publisherRelationship":1694,"citationCount":26,"citationInfo":26,"publishDate":1708,"publishYear":1709,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"8690e7a7-a16b-4fa1-8f58-60a25b33ffea","2024-01-08T07:38:08.545+00:00","2024-12-25T18:28:43.152+00:00",[],"Tratamiento-de-los-quistes-de-ovario",{"references":1563,"title":1565,"doi":1567},{"VOID":1564},"Demont, 2001, Epidemiology of apparently benign ovarian cysts, J Gynecol Obstet Biol Reprod, 30, S8\nLansac J. Prise en charge des kystes de l’ovaire présumés bénins. CNGOF - Collège national des gynécologues et obstétriciens français. RPCzotero:\u002F\u002Fattachment\u002F19\u002F. [accessed 4 Apr 2013].\nMimoun, 2013, Epidemiology of presumed benign ovarian tumors, J Gynecol Obstet Biol Reprod, 42, 722, 10.1016\u002Fj.jgyn.2013.09.027\nGreenlee, 2010, Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial, Am J Obstet Gynecol, 202, 373.e1, 10.1016\u002Fj.ajog.2009.11.029\nChristensen, 2002, Functional ovarian cysts in premenopausal and gynecologically healthy women, Contraception, 66, 153, 10.1016\u002FS0010-7824(02)00353-0\nValentin, 2002, The natural history of adnexal cysts incidentally detected at transvaginal ultrasound examination in postmenopausal women, Ultrasound Obstet Gynecol, 20, 174, 10.1046\u002Fj.1469-0705.2002.00709.x\nHoo, 2010, Expectant management of ultrasonically diagnosed ovarian dermoid cysts: is it possible to predict outcome?, Ultrasound Obstet Gynecol, 36, 235, 10.1002\u002Fuog.7610\nDemir, 2012, Adnexal masses suspected to be benign treated with laparoscopy, JSLS, 16, 71, 10.4293\u002F108680812X13291597716069\nBorgfeldt, 1999, Transvaginal sonographic ovarian findings in a random sample of women 25–40 years old, Ultrasound Obstet Gynecol, 13, 345, 10.1046\u002Fj.1469-0705.1999.13050345.x\nBar-Hava, 1997, Ovarian cysts and cyclic hormone replacement therapy: is there an association?, Acta Obstet Gynecol Scand, 76, 563, 10.3109\u002F00016349709024585\nHolt, 2005, Risk of functional ovarian cyst: effects of smoking and marijuana use according to body mass index, Am J Epidemiol, 161, 520, 10.1093\u002Faje\u002Fkwi080\nCotte B, Haag T, Vaudoyer F, Canis M, Mage G. Échographie des kystes et tumeurs de l’ovaire. EMC (Elsevier Masson SAS, Paris), Gynécologie, 680-A-26, 2011.\nBailey, 1998, The malignant potential of small cystic ovarian tumors in women over 50 years of age, Gynecol Oncol, 69, 3, 10.1006\u002Fgyno.1998.4965\nMacKenna, 2000, Clinical management of functional ovarian cysts: a prospective and randomized study, Hum Reprod, 15, 2567, 10.1093\u002Fhumrep\u002F15.12.2567\nBourdel, 2013, Treatment strategies in presumed benign ovarian tumors, J Gynecol Obstet Biol Reprod, 42, 802, 10.1016\u002Fj.jgyn.2013.09.035\nCanis, 1997, Operative laparoscopy and the adnexal cystic mass: where to set the limit?, J Gynecol Obstet Biol Reprod, 26, 293\nGhaemmaghami, 2008, Clinical assessment, gross examination, frozen section of ovarian masses: do patients benefit?, Arch Gynecol Obstet, 278, 209, 10.1007\u002Fs00404-007-0553-8\nAmerican College of Obstetricians anf Gynecologists, 2002, ACOG Committee Opinion: number 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer, Obstet Gynecol, 100, 1413\nDearking, 2007, How relevant are ACOG and SGO guidelines for referral of adnexal mass?, Obstet Gynecol, 110, 841, 10.1097\u002F01.AOG.0000267198.25223.bc\nLaculle-Massin, 2013, Diagnosis of presumed benign ovarian tumors, J Gynecol Obstet Biol Reprod, 42, 760, 10.1016\u002Fj.jgyn.2013.09.031\nLansac J, Bonnamy L. Présentation clinique des tumeurs bénignes et malignes de l’ovaire. EMC (Elsevier Masson SAS, Paris), Gynécologie, 630-D-10, 2000 : 4 p.\nDodge, 2012, Management of a suspicious adnexal mass: a clinical practice guideline, Curr Oncol, 19, e244, 10.3747\u002Fco.19.980\nTimmerman, 2000, Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group, Ultrasound Obstet Gynecol, 16, 500, 10.1046\u002Fj.1469-0705.2000.00287.x\nMarret, 2013, Sonographic diagnosis of presumed benign ovarian tumors, J Gynecol Obstet Biol Reprod, 42, 730, 10.1016\u002Fj.jgyn.2013.09.028\nMedeiros, 2009, Accuracy of ultrasonography with color Doppler in ovarian tumor: a systematic quantitative review, Int J Gynecol Cancer, 19, 1214, 10.1111\u002FIGC.0b013e3181a386e5\nVan Calster, 2007, Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125, J Natl Cancer Inst, 99, 1706, 10.1093\u002Fjnci\u002Fdjm199\nAslam, 2000, Prospective evaluation of three different models for the pre-operative diagnosis of ovarian cancer, BJOG, 107, 1347, 10.1111\u002Fj.1471-0528.2000.tb11646.x\nLin, 2013, Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis, Eur J Obstet Gynecol Reprod Biol, 167, 81, 10.1016\u002Fj.ejogrb.2012.10.036\nFerraro, 2013, Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review, J Clin Pathol, 66, 273, 10.1136\u002Fjclinpath-2012-201031\nMoore, 2009, A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass, Gynecol Oncol, 112, 40, 10.1016\u002Fj.ygyno.2008.08.031\nMontagnana, 2011, The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?, Clin Chem Lab Med, 49, 521, 10.1515\u002FCCLM.2011.075\nLi, 2012, Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis, BMC Cancer, 12, 258, 10.1186\u002F1471-2407-12-258\nJacobs, 1990, A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer, Br J Obstet Gynaecol, 97, 922, 10.1111\u002Fj.1471-0528.1990.tb02448.x\nGeomini, 2009, The accuracy of risk scores in predicting ovarian malignancy: a systematic review, Obstet Gynecol, 113, 384, 10.1097\u002FAOG.0b013e318195ad17\nAnton, 2012, A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses, Clinics (Sao Paulo), 67, 437, 10.6061\u002Fclinics\u002F2012(05)06\nBoll, 2003, The pre-operative assessment of the adnexal mass: the accuracy of clinical estimates versus clinical prediction rules, BJOG, 110, 519, 10.1046\u002Fj.1471-0528.2003.02361.x\nCaspi, 1997, The growth pattern of ovarian dermoid cysts: a prospective study in premenopausal and postmenopausal women, Fertil Steril, 68, 501, 10.1016\u002FS0015-0282(97)00228-8\nAlcázar, 2013, Expectant management of adnexal masses in selected premenopausal women: a prospective observational study, Ultrasound Obstet Gynecol, 41, 582, 10.1002\u002Fuog.12369\nRedwine, 1999, Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease, Fertil Steril, 72, 310, 10.1016\u002FS0015-0282(99)00211-3\nChapron, 2001, Management of endometriosis ovarian cysts, J Gynecol Obstet Biol Reprod, 30, S78\nDunselman, 2014, ESHRE guideline: management of women with endometriosis, Hum Reprod, 29, 400, 10.1093\u002Fhumrep\u002Fdet457\nAlborzi, 2004, A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas, Fertil Steril, 82, 1633, 10.1016\u002Fj.fertnstert.2004.04.067\nQuerleu D, Leblanc E. Cancer épithélial de l’ovaire : bilan et chirurgie. EMC (Elsevier Masson SAS, Paris), Gynécologie, 630-I-10, 2000.\nMedeiros, 2009, Laparoscopy versus laparotomy for benign ovarian tumour, Cochrane Database Syst Rev, CD004751\nCanis, 2001, Risk of spread of ovarian cancer after laparoscopic surgery, Curr Opin Obstet Gynecol, 13, 9, 10.1097\u002F00001703-200102000-00002\nPark, 2013, Staging laparoscopy for the management of early-stage ovarian cancer: a meta-analysis, Am J Obstet Gynecol, 209, 58.e1, 10.1016\u002Fj.ajog.2013.04.013\nLawrie, 2013, Laparoscopy versus laparotomy for FIGO stage I ovarian cancer, Cochrane Database Syst Rev, CD005344\nLim, 2012, Is tumor size the limiting factor in a laparoscopic management for large ovarian cysts?, Arch Gynecol Obstet, 286, 1227, 10.1007\u002Fs00404-012-2445-9\nBorghese, 2013, Surgical treatments of presumed benign ovarian tumors, J Gynecol Obstet Biol Reprod, 42, 786, 10.1016\u002Fj.jgyn.2013.09.033\nVergote, 2001, Prognostic factors in stage I ovarian carcinoma, Verh K Acad Geneeskd Belg, 63, 257\nLee, 2011, An easy new approach to the laparoscopic treatment of large adnexal cysts, Minim Invasive Ther Allied Technol, 20, 150, 10.3109\u002F13645706.2010.531543\nBakkum-Gamez, 2009, Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer, Obstet Gynecol, 113, 11, 10.1097\u002FAOG.0b013e3181917a0c\nMorelli, 2012, Mesial side ovarian incision for laparoscopic dermoid cystectomy: a safe and ovarian tissue-preserving technique, Fertil Steril, 98, 10.1016\u002Fj.fertnstert.2012.07.1112\nWeinstein, 1975, The role of wedge resection of the ovary as a cause for mechanical sterility, Surg Gynecol Obstet, 141, 417\nAhmad, 2008, Barrier agents for adhesion prevention after gynaecological surgery, Cochrane Database Syst Rev, CD000475\nTrew, 2011, Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery, Hum Reprod, 26, 2015, 10.1093\u002Fhumrep\u002Fder135\nKondo, 2010, Does prevention of intraperitoneal spillage when removing a dermoid cyst prevent granulomatous peritonitis?, BJOG, 117, 1027, 10.1111\u002Fj.1471-0528.2010.02580.x\nMuzii, 2010, Combined technique of excision and ablation for the surgical treatment of ovarian endometriomas: the way forward?, Reprod Biomed Online, 20, 300, 10.1016\u002Fj.rbmo.2009.11.014\nSomigliana, 2012, Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications, Fertil Steril, 98, 1531, 10.1016\u002Fj.fertnstert.2012.08.009\nYazbeck, 2009, Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation, Reprod Biomed Online, 19, 121, 10.1016\u002FS1472-6483(10)60055-7\nMuzii, 1996, The impact of preoperative gonadotropin-releasing hormone agonist treatment on laparoscopic excision of ovarian endometriotic cysts, Fertil Steril, 65, 1235, 10.1016\u002FS0015-0282(16)58346-0\nBrun, 2008, Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors, Am J Obstet Gynecol, 199, 244.e1, 10.1016\u002Fj.ajog.2008.04.002\nDekel, 1996, The residual ovary syndrome: a 20-year experience, Eur J Obstet Gynecol Reprod Biol, 68, 159, 10.1016\u002F0301-2115(96)00250-3\nFignon, 1998, Bilateral ovarian removal during hysterectomy: what is done and what should be done, Eur J Obstet Gynecol Reprod Biol, 76, 201, 10.1016\u002FS0301-2115(97)00170-X\nParker, 2007, Ovarian conservation at the time of hysterectomy for benign disease, Clin Obstet Gynecol, 50, 354, 10.1097\u002FGRF.0b013e31804a838d\nParker, 2005, Ovarian conservation at the time of hysterectomy for benign disease, Obstet Gynecol, 106, 219, 10.1097\u002F01.AOG.0000167394.38215.56\nRocca, 2012, Oophorectomy for whom and at what age? Primum non nocere, Maturitas, 71, 1, 10.1016\u002Fj.maturitas.2011.10.006\nMelton, 2003, Fracture risk after bilateral oophorectomy in elderly women, J Bone Miner Res, 18, 900, 10.1359\u002Fjbmr.2003.18.5.900\nRocca, 2011, Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity, Brain Res, 1379, 188, 10.1016\u002Fj.brainres.2010.10.031\n2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nParker, 2010, Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health, J Minim Invasive Gynecol, 17, 161, 10.1016\u002Fj.jmig.2009.12.016\nBuell-Gutbrod, 2013, Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei, Am Soc Clin Oncol Educ Book, 2013, 221, 10.1200\u002FEdBook_AM.2013.33.221\nRamirez, 2006, Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer, Gynecol Oncol, 103, 888, 10.1016\u002Fj.ygyno.2006.05.021\nYemelyanova, 2008, Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification, Am J Surg Pathol, 32, 128, 10.1097\u002FPAS.0b013e3180690d2d\nLin, 2013, The role of appendectomy for mucinous ovarian neoplasms, Am J Obstet Gynecol, 208, 46.e1, 10.1016\u002Fj.ajog.2012.10.863\nGrimes, 2011, Oral contraceptives for functional ovarian cysts, Cochrane Database Syst Rev, CD006134\nHidalgo, 2006, Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants, Contraception, 73, 532, 10.1016\u002Fj.contraception.2005.12.012\nThomin, 2013, Medical treatments of presumed benign ovarian tumors, J Gynecol Obstet Biol Reprod (Paris), 42, 774, 10.1016\u002Fj.jgyn.2013.09.032\nTsujioka, 2009, The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas, J Obstet Gynaecol Res, 35, 782, 10.1111\u002Fj.1447-0756.2009.01017.x\nLee, 2010, Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence, Hum Reprod, 25, 3050, 10.1093\u002Fhumrep\u002Fdeq279\nSeracchioli, 2010, Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial, Fertil Steril, 93, 52, 10.1016\u002Fj.fertnstert.2008.09.052\nXu, 2011, Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study, Zhonghua Yi Xue Za Zhi, 91, 1047\n2000, ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists, Int J Gynaecol Obstet, 71, 183, 10.1016\u002FS0020-7292(00)80034-X\nKoutlaki, 2011, Transvaginal aspiration of ovarian cysts: our experience over 121 cases, Minim Invasive Ther Allied Technol, 20, 155, 10.3109\u002F13645706.2010.532220\nSarfati R, Magnin G. Traitement chirurgical des tumeurs bénignes de l’ovaire. EMC (Elsevier Masson SAS, Paris), Gynécologie, 630-H-10, 2000 : 8 p.\nTsafrir, 2012, Adnexal torsion: cystectomy and ovarian fixation are equally important in preventing recurrence, Eur J Obstet Gynecol Reprod Biol, 162, 203, 10.1016\u002Fj.ejogrb.2012.02.027\nSpinelli, 2013, Adnexal torsion in children and adolescents: new trends to conservative surgical approach – our experience and review of literature, Gynecol Endocrinol, 29, 54, 10.3109\u002F09513590.2012.705377\nPansky, 2007, Torsion of normal adnexa in postmenarchal women and risk of recurrence, Obstet Gynecol, 109, 355, 10.1097\u002F01.AOG.0000250969.15438.17\nSozen, 2002, Diagnosis and laparoscopic management of a fallopian tube torsion following Irving tubal sterilization: a case report, Surg Endosc, 16, 217, 10.1007\u002Fs004640041031\nHuchon, 2010, Adnexal torsion: a predictive score for pre-operative diagnosis, Hum Reprod, 25, 2276, 10.1093\u002Fhumrep\u002Fdeq173\nBar-On, 2010, Emergency laparoscopy for suspected ovarian torsion: are we too hasty to operate?, Fertil Steril, 93, 2012, 10.1016\u002Fj.fertnstert.2008.12.022\nMazouni, 2005, Diagnosis of adnexal torsion and predictive factors of adnexal necrosis, Gynecol Obstet Fertil, 33, 102, 10.1016\u002Fj.gyobfe.2005.02.014\nValsky, 2010, Added value of the gray-scale whirlpool sign in the diagnosis of adnexal torsion, Ultrasound Obstet Gynecol, 36, 630, 10.1002\u002Fuog.7732\nMalamas, 2012, Adnexal torsion: don’t give up on the ovary, J Obstet Gynaecol, 32, 314, 10.3109\u002F01443615.2011.645093\nDeffieux, 2013, Complications of presumed benign ovarian tumors, J Gynecol Obstet Biol Reprod, 42, 816, 10.1016\u002Fj.jgyn.2013.09.036\nOelsner, 2003, Minimal surgery for the twisted ischaemic adnexa can preserve ovarian function, Hum Reprod, 18, 2599, 10.1093\u002Fhumrep\u002Fdeg498\nPatel, 2005, The likelihood ratio of sonographic findings for the diagnosis of hemorrhagic ovarian cysts, J Ultrasound Med, 24, 607, 10.7863\u002Fjum.2005.24.5.607\nAsch, 2007, Variations in appearance of endometriomas, J Ultrasound Med, 26, 993, 10.7863\u002Fjum.2007.26.8.993\nOutwater, 1993, Characterization of hemorrhagic adnexal lesions with MR imaging: blinded reader study, Radiology, 186, 489, 10.1148\u002Fradiology.186.2.8421756\nHo, 2009, Ruptured corpus luteum with hemoperitoneum: case characteristics and demographic changes over time, Taiwan J Obstet Gynecol, 48, 108, 10.1016\u002FS1028-4559(09)60267-9",{"ES":1566},"Tratamiento de los quistes de ovario",{"VOID":1568},"10.1016\u002Fs1283-081x(16)79121-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X16791211",[1571,1586,1598,1610,1622,1634,1646,1658,1670,1682],{"id":1572,"sortIndex":115,"researcher":26,"roles":1573,"affiliations":1574,"properties":1583},"891f195f-fc53-4b70-b3d7-eee9dd527ca9",[696],[1575],{"id":26,"sortIndex":36,"affiliation":1576,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1579,"slug":26,"properties":1580,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4db2230d-2c1a-4184-aee2-bdaff8edd05f","2024-01-08T07:38:08.699+00:00",[],{"title":1581},{"VI":1582},"Service de gynécologie obstétrique, Hôpital de Hautepierre, 1, avenue Molière, 67100 Strasbourg, France",{"title":1584},{"VI":1585},"A. Gaudineau",{"id":1587,"sortIndex":114,"researcher":26,"roles":1588,"affiliations":1589,"properties":1595},"a527db97-b725-4a8c-878a-edc9a15e3148",[696],[1590],{"id":26,"sortIndex":36,"affiliation":1591,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1592,"slug":26,"properties":1593,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1594},{"VI":1582},{"title":1596},{"VI":1597},"V. Thoma",{"id":1599,"sortIndex":50,"researcher":26,"roles":1600,"affiliations":1601,"properties":1607},"ce9c179c-4731-47bc-a687-8a5d3ce19afa",[696],[1602],{"id":26,"sortIndex":36,"affiliation":1603,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1604,"slug":26,"properties":1605,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1606},{"VI":1582},{"title":1608},{"VI":1609},"J.-J. Baldauf",{"id":1611,"sortIndex":36,"researcher":26,"roles":1612,"affiliations":1613,"properties":1619},"60566c3c-76bd-45a6-9c26-8de1c2a16031",[696],[1614],{"id":26,"sortIndex":36,"affiliation":1615,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1616,"slug":26,"properties":1617,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1618},{"VI":1582},{"title":1620},{"VI":1621},"S. Bel",{"id":1623,"sortIndex":52,"researcher":26,"roles":1624,"affiliations":1625,"properties":1631},"e125d66a-9eb5-4a6c-ab72-baf9b7dacdd1",[696],[1626],{"id":26,"sortIndex":36,"affiliation":1627,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1628,"slug":26,"properties":1629,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1630},{"VI":1582},{"title":1632},{"VI":1633},"C. Akladios",{"id":1635,"sortIndex":59,"researcher":26,"roles":1636,"affiliations":1637,"properties":1643},"da6a5c75-c5dd-48d8-823f-2eee4681a4b7",[696],[1638],{"id":26,"sortIndex":36,"affiliation":1639,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1640,"slug":26,"properties":1641,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1642},{"VI":1582},{"title":1644},{"VI":1645},"O. Garbin",{"id":1647,"sortIndex":135,"researcher":26,"roles":1648,"affiliations":1649,"properties":1655},"e8611044-d062-4c49-a085-c5b14071f3d4",[696],[1650],{"id":26,"sortIndex":36,"affiliation":1651,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1652,"slug":26,"properties":1653,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1654},{"VI":1582},{"title":1656},{"VI":1657},"M. Hummel",{"id":1659,"sortIndex":111,"researcher":26,"roles":1660,"affiliations":1661,"properties":1667},"51331724-7fdb-4ade-a2ed-56369006d93b",[696],[1662],{"id":26,"sortIndex":36,"affiliation":1663,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1664,"slug":26,"properties":1665,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1666},{"VI":1582},{"title":1668},{"VI":1669},"N. Sananes",{"id":1671,"sortIndex":162,"researcher":26,"roles":1672,"affiliations":1673,"properties":1679},"fd3fddee-900e-4dc6-9426-52c59cf72619",[696],[1674],{"id":26,"sortIndex":36,"affiliation":1675,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1676,"slug":26,"properties":1677,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1678},{"VI":1582},{"title":1680},{"VI":1681},"E. Baulon",{"id":1683,"sortIndex":158,"researcher":26,"roles":1684,"affiliations":1685,"properties":1691},"3c973d6c-b371-4921-8fe5-4ee2cb4c04af",[696],[1686],{"id":26,"sortIndex":36,"affiliation":1687,"properties":26},{"id":1577,"createTime":1578,"updateTime":1578,"relativeEntities":1688,"slug":26,"properties":1689,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1690},{"VI":1582},{"title":1692},{"VI":1693},"A. Wattiez",{"url":1569,"publisher":1695,"properties":1703},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1696,"slug":662,"properties":1697,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1700,"manageAffiliations":1701,"indexDatabases":1702,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1698,"title":1699},{"VOID":665},{"EN":667},[],[],[],{"volume":1704,"pages":1706},{"VOID":1705},"52",{"VOID":1707},"1-16","2016-12-01",2016]